This is a Validated Antibody Database (VAD) review about human PTEN, based on 266 published articles (read how Labome selects the articles), using PTEN antibody in all methods. It is aimed to help Labome visitors find the most suited PTEN antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PTEN synonym: 10q23del; BZS; CWS1; DEC; GLM2; MHAM; MMAC1; PTEN1; PTENbeta; TEP1

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (A2b1)
  • western blot knockout validation; human; 1:500; fig 5
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot knockout validation on human samples at 1:500 (fig 5). PLoS ONE (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; loading ...; fig s1b
Cell Signaling Technology PTEN antibody (CST, 9188) was used in western blot knockout validation on mouse samples (fig s1b). Cell Death Dis (2022) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; fig 1a
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples (fig 1a) and in immunohistochemistry - paraffin section on mouse samples (fig 3c). Cancers (Basel) (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 2a, 5b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2a, 5b). Proc Natl Acad Sci U S A (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; loading ...; fig 3e
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot knockout validation on mouse samples (fig 3e). Adv Sci (Weinh) (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 138G6) was used in western blot knockout validation on human samples at 1:1000 (fig 3e). BMC Cancer (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s2e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples at 1:1000 (fig s2e). Nat Commun (2021) ncbi
Cell Signaling Technology
mouse monoclonal (26H9)
  • western blot knockout validation; mouse; fig s1c
  • immunohistochemistry; mouse; fig 1b
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9556) was used in western blot knockout validation on mouse samples (fig s1c) and in immunohistochemistry on mouse samples (fig 1b). Cell (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 1a
  • western blot knockout validation; human; loading ...; fig 5g, s4a
Cell Signaling Technology PTEN antibody (CST, 9559) was used in western blot knockout validation on mouse samples (fig 1a) and in western blot knockout validation on human samples (fig 5g, s4a). Cell Death Dis (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; human; loading ...; fig 2d, 2h
Cell Signaling Technology PTEN antibody (Cell signaling, 9559S) was used in western blot knockout validation on human samples (fig 2d, 2h). elife (2020) ncbi
Cell Signaling Technology
mouse monoclonal (26H9)
  • immunohistochemistry knockout validation; mouse; 1:100; loading ...; fig 1b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9556S) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 1b). Int J Mol Sci (2020) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 2b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559L) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2b). Mol Cancer Ther (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 5a
Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in western blot knockout validation on mouse samples (fig 5a). Nat Commun (2018) ncbi
Cell Signaling Technology
mouse monoclonal (26H9)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 5c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9556) was used in western blot knockout validation on mouse samples at 1:1000 (fig 5c). Nat Commun (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 2a
  • immunohistochemistry; human; loading ...; fig s6k
In order to understand the interaction between PTEN and FBXL2 in the context of apoptosis, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559S) was used in western blot knockout validation on mouse samples (fig 2a) and in immunohistochemistry on human samples (fig s6k). Nature (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; loading ...; fig s3a
In order to investigate the interplay among ETS factors in prostate oncogenesis, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples (fig s3a). Nature (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D4.3)
  • immunocytochemistry knockout validation; mouse; 1:300; fig s1a
  • western blot; mouse; 1:2000; fig 1c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunocytochemistry knockout validation on mouse samples at 1:300 (fig s1a) and in western blot on mouse samples at 1:2000 (fig 1c). Nat Commun (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot; mouse; fig 1
  • western blot knockout validation; human; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples (fig 1) and in western blot knockout validation on human samples (fig 1). Cell Discov (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • immunohistochemistry knockout validation; rat; 1:50; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry knockout validation on rat samples at 1:50 (fig 1). Sci Rep (2016) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 5a
In order to show that pituitary tumor transforming gene 1 expression is upregulated in an mammalian/mechanistic target of rapamycin complex 1-dependent manner, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot knockout validation on mouse samples (fig 5a). Oncogene (2017) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • immunohistochemistry knockout validation; rat; 1:50; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry knockout validation on rat samples at 1:50 (fig 1). Development (2015) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 9b
Cell Signaling Technology PTEN antibody (Cell signaling, 9559) was used in western blot knockout validation on mouse samples (fig 9b). Mol Cell Biol (2014) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • immunohistochemistry knockout validation; mouse; fig 3
In order to investigate the influence of PTEN on prostate adenocarcinoma development and its mechanism, Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in immunohistochemistry knockout validation on mouse samples (fig 3). Am J Pathol (2009) ncbi
Abcam
domestic rabbit monoclonal (EPR22636-122)
  • western blot; human; loading ...; fig 3j
Abcam PTEN antibody (Abcam, ab267787) was used in western blot on human samples (fig 3j). Int J Mol Sci (2022) ncbi
domestic rabbit monoclonal (EPR22636-122)
  • western blot; human; loading ...; fig 3a
Abcam PTEN antibody (Abcam, ab267787) was used in western blot on human samples (fig 3a). Thorac Cancer (2022) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; loading ...; fig 5b
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples (fig 5b). Clin Transl Med (2022) ncbi
domestic rabbit monoclonal (EPR22636-122)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1e
Abcam PTEN antibody (Abcam, ab267787) was used in immunohistochemistry - paraffin section on human samples (fig 1e). J Cancer (2021) ncbi
domestic rabbit monoclonal
  • western blot; human; 1:1000; loading ...; fig 8
Abcam PTEN antibody (Abcam, ab170941) was used in western blot on human samples at 1:1000 (fig 8). Exp Ther Med (2021) ncbi
domestic rabbit monoclonal
  • western blot; rat; 1:5000; loading ...; fig 5d
Abcam PTEN antibody (Abcam, ab154812) was used in western blot on rat samples at 1:5000 (fig 5d). Cell Death Discov (2021) ncbi
domestic rabbit monoclonal
  • flow cytometry; mouse; 1:500; fig 1f
Abcam PTEN antibody (Abcam, ab170941) was used in flow cytometry on mouse samples at 1:500 (fig 1f). Proc Natl Acad Sci U S A (2021) ncbi
domestic rabbit monoclonal (EPR22636-122)
  • western blot; human; loading ...; fig 7d
Abcam PTEN antibody (Abcam, ab267787) was used in western blot on human samples (fig 7d). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; mouse; 1:200; fig 5b
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on mouse samples at 1:200 (fig 5b). Front Cell Neurosci (2021) ncbi
domestic rabbit monoclonal (EPR22636-122)
  • immunohistochemistry; mouse; loading ...; fig 6a
  • western blot; mouse; loading ...; fig 4c
Abcam PTEN antibody (Abcam, ab267787) was used in immunohistochemistry on mouse samples (fig 6a) and in western blot on mouse samples (fig 4c). Front Cell Dev Biol (2021) ncbi
domestic rabbit monoclonal
  • immunohistochemistry; mouse; 1:100; loading ...; fig 1g
Abcam PTEN antibody (Abcam, 170941) was used in immunohistochemistry on mouse samples at 1:100 (fig 1g). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; 1:1000; fig 7b
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples at 1:1000 (fig 7b). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; 1:1000; fig 7b
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples at 1:1000 (fig 7b). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; 1:1000; fig 7b
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples at 1:1000 (fig 7b). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; 1:1000; fig 7b
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples at 1:1000 (fig 7b). Aging (Albany NY) (2021) ncbi
domestic rabbit monoclonal
  • immunohistochemistry - paraffin section; rat; 1:100; loading ...; fig 7d
Abcam PTEN antibody (Abcam, ab170941) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 7d). J Neuroinflammation (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; loading ...; fig 2c
Abcam PTEN antibody (Abcam, ab31392) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2c). Sci Rep (2020) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; 1:1000; loading ...; fig s8h
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples at 1:1000 (fig s8h). Nat Commun (2019) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; loading ...; fig 5i
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples (fig 5i). Cancers (Basel) (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3a
  • western blot; mouse; 1:1500; loading ...; fig 2e
Abcam PTEN antibody (Abcam, ab31392) was used in immunohistochemistry - paraffin section on mouse samples (fig 3a) and in western blot on mouse samples at 1:1500 (fig 2e). Biochem Biophys Res Commun (2018) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; fig 6a
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples (fig 6a). Placenta (2017) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; 1:10,000; fig 6d
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples at 1:10,000 (fig 6d). Mol Cell Biochem (2016) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry - frozen section; mouse; fig 4g
Abcam PTEN antibody (abcam, ab32199) was used in immunohistochemistry - frozen section on mouse samples (fig 4g). Sci Rep (2016) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; fig s12
Abcam PTEN antibody (Abcam, Y184) was used in western blot on human samples (fig s12). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to assess PTEN expression by immunopathology, Abcam PTEN antibody (Abcam, ab32199) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Methods Mol Biol (2016) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; mouse; fig 4
In order to elucidate miR-21 that induces fibrosis in an acute cardiac allograft transplantation model, Abcam PTEN antibody (Abcam, ab32199) was used in western blot on mouse samples (fig 4). Cardiovasc Res (2016) ncbi
domestic rabbit monoclonal (Y184)
  • flow cytometry; human; fig 5
  • western blot; human; fig 5
Abcam PTEN antibody (Abcam, Ab32199) was used in flow cytometry on human samples (fig 5) and in western blot on human samples (fig 5). Sci Rep (2015) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry; mouse; 1:25; fig 1
Abcam PTEN antibody (Abcam, 32199) was used in immunohistochemistry on mouse samples at 1:25 (fig 1). Nat Commun (2015) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; fig 8
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples (fig 8). J Clin Invest (2015) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to identify biomarkers using HER2-positive advanced breast cancer samples from patients treated with trastuzumab and paclitaxel combination chemotherapy, Abcam PTEN antibody (Abcam,, ab32199) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Tumour Biol (2015) ncbi
domestic rabbit monoclonal (Y184)
  • western blot; human; loading ...; fig 2a
Abcam PTEN antibody (Abcam, ab32199) was used in western blot on human samples (fig 2a). Oncol Rep (2015) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry; human; tbl 2
In order to use endometrial carcinoma as a three-dimensional model to study PTEN deficiency, Abcam PTEN antibody (ABCAM, Ab32199) was used in immunohistochemistry on human samples (tbl 2). Methods (2015) ncbi
domestic rabbit monoclonal (Y184)
  • chromatin immunoprecipitation; human; 1:100
  • immunoprecipitation; human; 1:100
Abcam PTEN antibody (Abcam, ab32199) was used in chromatin immunoprecipitation on human samples at 1:100 and in immunoprecipitation on human samples at 1:100. Am J Pathol (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human
Abcam PTEN antibody (Abcam, ab79156) was used in western blot on human samples . Curr Mol Med (2014) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry - paraffin section; human; 1:250
  • western blot; human
In order to evaluate the effect of NVP-BEZ235 and MEK inhibitor ADZ4266 on murine mismatch repair deficient tumors, Abcam PTEN antibody (Abcam, AB32199) was used in immunohistochemistry - paraffin section on human samples at 1:250 and in western blot on human samples . PLoS ONE (2013) ncbi
domestic rabbit monoclonal (Y184)
  • immunohistochemistry - paraffin section; human; 1:100
Abcam PTEN antibody (ABCAM, Ab32199) was used in immunohistochemistry - paraffin section on human samples at 1:100. Acta Histochem (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A2b1)
  • immunohistochemistry - frozen section; mouse; 1:300; fig 7f
  • western blot; mouse; 1:2500; loading ...; fig 4a, 7g
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 8f
  • western blot; human; 1:2500; loading ...; fig 6a, 6b, 6c, 8k
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in immunohistochemistry - frozen section on mouse samples at 1:300 (fig 7f), in western blot on mouse samples at 1:2500 (fig 4a, 7g), in immunohistochemistry - paraffin section on human samples at 1:300 (fig 8f) and in western blot on human samples at 1:2500 (fig 6a, 6b, 6c, 8k). Clin Transl Med (2021) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:500; loading ...; fig 7d
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples at 1:500 (fig 7d). Cancers (Basel) (2021) ncbi
mouse monoclonal (A2b1)
  • western blot; rat; 1:1000; loading ...; fig 3
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on rat samples at 1:1000 (fig 3). Animals (Basel) (2020) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse; 1:1000; loading ...; fig 7a
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on mouse samples at 1:1000 (fig 7a). Restor Neurol Neurosci (2018) ncbi
mouse monoclonal (A2b1)
  • immunoprecipitation; human; loading ...; fig 4d
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in immunoprecipitation on human samples (fig 4d). Mol Cell (2017) ncbi
mouse monoclonal (F-1)
  • western blot; human; fig s3d
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-393186) was used in western blot on human samples (fig s3d). Nature (2017) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:500; loading ...; fig 6a
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples at 1:500 (fig 6a). PLoS ONE (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:1000; loading ...; fig 7
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, A2B1) was used in western blot on human samples at 1:1000 (fig 7). Oncotarget (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:1000; fig s7
In order to elucidate the mechanisms by which mutant IDH1/2 contributes to oncogenesis, Santa Cruz Biotechnology PTEN antibody (Santa Cruz, A2B1) was used in western blot on human samples at 1:1000 (fig s7). Nat Commun (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:200; loading ...; fig s3
In order to research the role of ORP4L for T-cell acute lymphoblastic leukemia cell survival, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples at 1:200 (fig s3). Nat Commun (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; fig 4D
In order to explore the role of NHERF1 in intestinal adenoma development, Santa Cruz Biotechnology PTEN antibody (Santa Cruz, A2B1) was used in western blot on human samples (fig 4D). Neoplasia (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; fig 5b
In order to develop a patient-derived xenograft platform and use it to identify genes that contribute the cancer resistance of melanoma patients treated with BRAF inhibitors, Santa Cruz Biotechnology PTEN antibody (Santa Cruz, A2B1) was used in western blot on human samples (fig 5b). Cell Rep (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; fig 2a
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, A2B1) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse; fig 4
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on mouse samples (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (A2b1)
  • immunocytochemistry; human; 1:50; loading ...
In order to study PTEN in mitochondria and endoplasmic reticulum, Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in immunocytochemistry on human samples at 1:50. Methods Mol Biol (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; dogs; 1:1000; fig 5A
In order to assess induction of renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway due to ZO-2 silencing, Santa Cruz Biotechnology PTEN antibody (Santa Cruz, Sc-7974) was used in western blot on dogs samples at 1:1000 (fig 5A). Mol Biol Cell (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; fig 4b
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc7974) was used in western blot on human samples (fig 4b). Oncogene (2016) ncbi
mouse monoclonal (A2b1)
  • western blot; human; fig 1
In order to study how ZEB1 drives the epithelial-mesenchymal transition-related resistance to EGFR-tyrosine kinases inhibitors in non-small cell lung cancer, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc7974) was used in western blot on human samples (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (A2b1)
  • immunoprecipitation; mouse; loading ...; fig 2b
  • western blot; mouse; loading ...; fig 2b
  • immunoprecipitation; human; loading ...; fig 2b
  • western blot; human; loading ...; fig 2b
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in immunoprecipitation on mouse samples (fig 2b), in western blot on mouse samples (fig 2b), in immunoprecipitation on human samples (fig 2b) and in western blot on human samples (fig 2b). Sci Rep (2015) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse; fig 8
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on mouse samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (A2b1)
  • western blot knockout validation; human; 1:500; fig 5
In order to identify the mechanism for apoptosis in colon cancer cells after depletion of PTEN, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot knockout validation on human samples at 1:500 (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse; 1:1000; fig 1b
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, SC-7974) was used in western blot on mouse samples at 1:1000 (fig 1b). Nat Commun (2015) ncbi
mouse monoclonal (A2b1)
  • western blot; human; loading ...; fig 1d
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on human samples (fig 1d). Nat Commun (2015) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse
In order to describe the multiple lentiviral expression (MuLE) system that allows multiple genetic alterations to be introduced simultaneously into mammalian cells, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on mouse samples . J Clin Invest (2015) ncbi
mouse monoclonal (A2b1)
  • western blot; human
In order to determine the action of PARP inhibition in different glioblastoma multiforme cell lines, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples . Oncotarget (2015) ncbi
mouse monoclonal (A2b1)
  • immunohistochemistry; mouse; 1:200
  • western blot; mouse; 1:500
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in immunohistochemistry on mouse samples at 1:200 and in western blot on mouse samples at 1:500. PLoS ONE (2014) ncbi
mouse monoclonal (G-6)
  • immunohistochemistry; human; tbl 2
In order to use endometrial carcinoma as a three-dimensional model to study PTEN deficiency, Santa Cruz Biotechnology PTEN antibody (Santa Cruz, SC-133242) was used in immunohistochemistry on human samples (tbl 2). Methods (2015) ncbi
mouse monoclonal (A2b1)
  • immunohistochemistry; mouse; fig 3
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in immunohistochemistry on mouse samples (fig 3). Mol Ther (2015) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse; fig 2
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, A2B1) was used in western blot on mouse samples (fig 2). Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (G-6)
  • immunohistochemistry - paraffin section; human; 1:100
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-133242) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Ophthalmol (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples . Int J Oncol (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:500
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on human samples at 1:500. Mol Cancer (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human; 1:200
In order to determine the cellular function of Lyar, Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on human samples at 1:200. Genes Cells (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on human samples . Anat Rec (Hoboken) (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; human; fig 1
Santa Cruz Biotechnology PTEN antibody (Santa Cruz, sc-7974) was used in western blot on human samples (fig 1). Oncogene (2014) ncbi
mouse monoclonal (A2b1)
  • western blot; mouse; 1:1000
Santa Cruz Biotechnology PTEN antibody (Santa Cruz Biotechnology, sc-7974) was used in western blot on mouse samples at 1:1000. PLoS ONE (2013) ncbi
Invitrogen
mouse monoclonal (1B8)
  • flow cytometry; mouse; fig s5a
Invitrogen PTEN antibody (eBioscience, 1B8) was used in flow cytometry on mouse samples (fig s5a). Nature (2019) ncbi
mouse monoclonal (2F4C9)
  • immunocytochemistry; human; 1:10; loading ...; fig 3b
  • immunocytochemistry; mouse; 1:10; loading ...; fig 3a
In order to discover that PTEN is a substrate of the ISGylation post-translational modification pathway, Invitrogen PTEN antibody (Thermo Scientific, 32-5800) was used in immunocytochemistry on human samples at 1:10 (fig 3b) and in immunocytochemistry on mouse samples at 1:10 (fig 3a). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 1a
In order to demonstrate that PTEN loss results in ADAM17 and NOTCH signaling in prostate cancer cells, Invitrogen PTEN antibody (Invitrogen, 51-2,400) was used in immunohistochemistry - paraffin section on mouse samples (fig 1a). Nat Commun (2016) ncbi
mouse monoclonal (17.A)
  • immunohistochemistry; human; loading ...; fig 3c
In order to describe the mechanism behind the association between single nucleotide polymorphism rs55705857 and glioma development., Invitrogen PTEN antibody (Thermo Fisher, MS-1601) was used in immunohistochemistry on human samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (17.A)
  • immunohistochemistry; human; 1:50; tbl 4
In order to study 3 cases of uterine adenomyosis/adenomyotic cysts of the cervical stump leading to serous carcinoma, Invitrogen PTEN antibody (Zymed, 17A) was used in immunohistochemistry on human samples at 1:50 (tbl 4). Diagn Pathol (2016) ncbi
mouse monoclonal (17.A)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to assess PTEN expression by immunopathology, Invitrogen PTEN antibody (NeoMarkers, MS1601) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Methods Mol Biol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; tbl 1
In order to assess PTEN expression by immunopathology, Invitrogen PTEN antibody (Life Technologies, 51-2400) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Methods Mol Biol (2016) ncbi
mouse monoclonal (17.A)
  • immunohistochemistry - paraffin section; human; loading ...; tbl 1
In order to evaluate the contribution of PTEN promoter methylation to sporadic breast cancer in patients from North India, Invitrogen PTEN antibody (Thermo Fisher, 17.A) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Breast Cancer (2016) ncbi
mouse monoclonal (17.A)
  • immunohistochemistry; human; tbl 2
In order to use endometrial carcinoma as a three-dimensional model to study PTEN deficiency, Invitrogen PTEN antibody (Thermo Scientific, MA5-12278) was used in immunohistochemistry on human samples (tbl 2). Methods (2015) ncbi
mouse monoclonal (17.A)
  • immunohistochemistry - paraffin section; human; 1:20
In order to identify diagnostic and prognostic markers for glioblastoma, Invitrogen PTEN antibody (Lab Vision, MS-1601) was used in immunohistochemistry - paraffin section on human samples at 1:20. Int J Oncol (2012) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:2000; loading ...; fig s4a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples at 1:2000 (fig s4a). iScience (2022) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; loading ...; fig 1c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on mouse samples (fig 1c). Cell Rep Methods (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9551S) was used in western blot on human samples (fig 5a). J Transl Med (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9552S) was used in western blot on human samples (fig 5a). J Transl Med (2022) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; loading ...; fig s1b
Cell Signaling Technology PTEN antibody (CST, 9188) was used in western blot knockout validation on mouse samples (fig s1b). Cell Death Dis (2022) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples at 1:1000 (fig 3e). Mol Ther Nucleic Acids (2022) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology PTEN antibody (CST, 138G6) was used in western blot on human samples at 1:1000 (fig 3c). J Cancer (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; fig 1a
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples (fig 1a) and in immunohistochemistry - paraffin section on mouse samples (fig 3c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; loading ...; fig s8a
Cell Signaling Technology PTEN antibody (CST, 9559) was used in western blot on mouse samples at 1:1000 (fig s8a). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 2g
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559s) was used in western blot on human samples (fig 2g). Bioeng Transl Med (2021) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 1g
  • western blot; mouse; 1:1000; loading ...; fig 3b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry on mouse samples at 1:200 (fig 1g) and in western blot on mouse samples at 1:1000 (fig 3b). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000; loading ...; fig 6b
Cell Signaling Technology PTEN antibody (CST, 9188T) was used in western blot on mouse samples at 1:1000 (fig 6b). J Cell Mol Med (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 2a, 5b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2a, 5b). Proc Natl Acad Sci U S A (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7b, s7a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples (fig 7b, s7a). iScience (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples (fig 5b). Front Immunol (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 5b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9551) was used in western blot on human samples (fig 5b). Front Immunol (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; loading ...; fig 3e
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot knockout validation on mouse samples (fig 3e). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7a
  • western blot; mouse; 1:2000; loading ...; fig 6c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples (fig 7a) and in western blot on mouse samples at 1:2000 (fig 6c). Nat Commun (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; human; 1:1000; loading ...; fig 3e
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 138G6) was used in western blot knockout validation on human samples at 1:1000 (fig 3e). BMC Cancer (2021) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; mouse; loading ...; fig 5a
  • western blot; mouse; loading ...; fig 5d
  • western blot; human; fig 5d
Cell Signaling Technology PTEN antibody (Cell signaling, 9559) was used in immunohistochemistry on mouse samples (fig 5a), in western blot on mouse samples (fig 5d) and in western blot on human samples (fig 5d). Nat Commun (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; loading ...; fig 3h
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188T) was used in western blot on mouse samples (fig 3h). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig s2e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples at 1:1000 (fig s2e). Nat Commun (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 3f
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559L) was used in western blot on human samples at 1:1000 (fig 3f). Front Synaptic Neurosci (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000; loading ...; fig 3d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on mouse samples at 1:1000 (fig 3d). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 3f, 5b
Cell Signaling Technology PTEN antibody (CST, 9188) was used in western blot on human samples at 1:1000 (fig 3f, 5b). Cell Death Discov (2021) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 4
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry on mouse samples at 1:1000 (fig 4). Oncoscience (2021) ncbi
mouse monoclonal (26H9)
  • western blot knockout validation; mouse; fig s1c
  • immunohistochemistry; mouse; fig 1b
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9556) was used in western blot knockout validation on mouse samples (fig s1c) and in immunohistochemistry on mouse samples (fig 1b). Cell (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology PTEN antibody (CST, 9188) was used in western blot on human samples (fig 5a). BMC Cancer (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; zebrafish ; 1:1000; loading ...; fig 3c
  • immunohistochemistry; human; loading ...; fig 8c
Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in western blot on zebrafish samples at 1:1000 (fig 3c) and in immunohistochemistry on human samples (fig 8c). Cancers (Basel) (2021) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000; loading ...; fig 5a, 5b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on mouse samples at 1:1000 (fig 5a, 5b). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 1a
  • western blot knockout validation; human; loading ...; fig 5g, s4a
Cell Signaling Technology PTEN antibody (CST, 9559) was used in western blot knockout validation on mouse samples (fig 1a) and in western blot knockout validation on human samples (fig 5g, s4a). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (44A7)
  • western blot; mouse; loading ...; fig ev1d-f
Cell Signaling Technology PTEN antibody (cell signaling, 9549) was used in western blot on mouse samples (fig ev1d-f). EMBO Mol Med (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; loading ...; fig ev1d-f
Cell Signaling Technology PTEN antibody (cell signaling, 9559) was used in western blot on mouse samples (fig ev1d-f). EMBO Mol Med (2021) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 138G5) was used in western blot on human samples (fig 3b). elife (2020) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 6a
Cell Signaling Technology PTEN antibody (CST, 9559) was used in western blot on human samples (fig 6a). Sci Rep (2020) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; human; loading ...; fig 2d, 2h
Cell Signaling Technology PTEN antibody (Cell signaling, 9559S) was used in western blot knockout validation on human samples (fig 2d, 2h). elife (2020) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 3b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples at 1:1000 (fig 3b). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5g
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9552S) was used in western blot on human samples at 1:1000 (fig 5g). J Clin Invest (2020) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; loading ...; fig s1d
Cell Signaling Technology PTEN antibody (CST, 9559) was used in western blot on mouse samples at 1:1000 (fig s1d). J Exp Med (2020) ncbi
mouse monoclonal (26H9)
  • immunohistochemistry knockout validation; mouse; 1:100; loading ...; fig 1b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9556S) was used in immunohistochemistry knockout validation on mouse samples at 1:100 (fig 1b). Int J Mol Sci (2020) ncbi
domestic rabbit monoclonal (D4.3)
  • immunoprecipitation; human; loading ...; fig 4d
  • western blot; human; 1:1000; loading ...; fig 6a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188S) was used in immunoprecipitation on human samples (fig 4d) and in western blot on human samples at 1:1000 (fig 6a). Theranostics (2020) ncbi
domestic rabbit monoclonal (D5G7)
  • western blot; mouse; 1:500; loading ...; fig 5b
Cell Signaling Technology PTEN antibody (CST, 5384S) was used in western blot on mouse samples at 1:500 (fig 5b). Sci Rep (2020) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; human; loading ...; fig 7i
  • western blot; human; loading ...; fig s5a
Cell Signaling Technology PTEN antibody (CST, 9188) was used in immunohistochemistry on human samples (fig 7i) and in western blot on human samples (fig s5a). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; human; 1:100; loading ...; fig 4
Cell Signaling Technology PTEN antibody (CST, mAb #9559) was used in immunohistochemistry on human samples at 1:100 (fig 4). Cancers (Basel) (2020) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 8a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188S) was used in western blot on human samples (fig 8a). Molecules (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:500-1:2000; loading ...; fig s2e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples at 1:500-1:2000 (fig s2e). Cell Rep (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 6c, 6f, s15b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples at 1:1000 (fig 6c, 6f, s15b). Nat Commun (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; rat; loading ...; fig 1a
Cell Signaling Technology PTEN antibody (Cell signaling, 9559) was used in western blot on rat samples (fig 1a). Cell Rep (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 1d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1d). Breast Cancer Res Treat (2020) ncbi
domestic rabbit monoclonal (44A7)
  • immunocytochemistry; human; loading ...; fig 1f
  • western blot; human; loading ...; fig 1e
Cell Signaling Technology PTEN antibody (Cell signalling, 9549s) was used in immunocytochemistry on human samples (fig 1f) and in western blot on human samples (fig 1e). Cells (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology PTEN antibody (Cell signalling, 9188s) was used in western blot on human samples (fig 1a). Cells (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 5a
Cell Signaling Technology PTEN antibody (CST, 9559) was used in western blot on human samples (fig 5a). Oncogene (2020) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 1s1a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (fig 1s1a). elife (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 2b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559L) was used in western blot knockout validation on mouse samples at 1:1000 (fig 2b). Mol Cancer Ther (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 2a, 2d, 2g, 2j
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (fig 2a, 2d, 2g, 2j). Nat Commun (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig ex4j
Cell Signaling Technology PTEN antibody (Cell Signaling, D4.3) was used in immunohistochemistry on mouse samples at 1:1000 (fig ex4j). Nature (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 4m
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples (fig 4m). Mol Cancer (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on human samples at 1:1000 (fig 1a). Cancer Discov (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188S) was used in western blot on human samples (fig 2d). Cancer Cell (2019) ncbi
domestic rabbit monoclonal (138G6)
  • immunoprecipitation; human; 1:500; loading ...; fig s2g
  • western blot; human; loading ...; fig s2g
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559) was used in immunoprecipitation on human samples at 1:500 (fig s2g) and in western blot on human samples (fig s2g). Science (2019) ncbi
domestic rabbit monoclonal (138G6)
  • mass cytometry; human; loading ...; fig 3a
Cell Signaling Technology PTEN antibody (Cell Signaling Technologies, 9559) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig s2b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188s) was used in western blot on human samples at 1:1000 (fig s2b). Nat Commun (2019) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 5d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry - paraffin section on mouse samples (fig 5d). Cell (2019) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 1c
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 1c). Gut (2020) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig s18a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188T) was used in western blot on human samples at 1:1000 (fig s18a). Aging (Albany NY) (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; loading ...; fig 3b
  • immunocytochemistry; human; loading ...; fig s3a
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on mouse samples (fig 3b), in immunocytochemistry on human samples (fig s3a) and in western blot on human samples (fig 3b). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 3c
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on human samples (fig 3c). J Clin Invest (2019) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 2e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on rat samples (fig 2e). Oxid Med Cell Longev (2018) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 4a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559) was used in western blot on human samples at 1:1000 (fig 4a). J Clin Invest (2019) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 5a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples (fig 5a). Cell Rep (2018) ncbi
domestic rabbit monoclonal (D4.3)
  • immunoprecipitation; rat; loading ...; fig 7c
  • western blot; rat; loading ...; fig 7c
  • immunoprecipitation; mouse; loading ...; fig 4e
  • western blot; mouse; loading ...; fig 4a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunoprecipitation on rat samples (fig 7c), in western blot on rat samples (fig 7c), in immunoprecipitation on mouse samples (fig 4e) and in western blot on mouse samples (fig 4a). Redox Biol (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 4a). Oncogene (2019) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; loading ...; fig s3a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on mouse samples (fig s3a). Immunity (2018) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 5a
Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in western blot knockout validation on mouse samples (fig 5a). Nat Commun (2018) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:2000; loading ...; fig 2d
Cell Signaling Technology PTEN antibody (CST, 9188) was used in western blot on mouse samples at 1:2000 (fig 2d). J Biol Chem (2018) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; fig 6d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on mouse samples (fig 6d). Nat Commun (2018) ncbi
domestic rabbit monoclonal (44A7)
  • western blot; mouse; fig 6d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9549) was used in western blot on mouse samples (fig 6d). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 7b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples (fig 7b). Biochim Biophys Acta Mol Basis Dis (2018) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; fig 1d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (fig 1d). Nat Commun (2018) ncbi
mouse monoclonal (26H9)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 5c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9556) was used in western blot knockout validation on mouse samples at 1:1000 (fig 5c). Nat Commun (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 4c
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559s) was used in western blot on human samples (fig 4c). Nat Med (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; loading ...; fig 4a, 4b
  • western blot; human; loading ...; fig 4b
Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in western blot on mouse samples (fig 4a, 4b) and in western blot on human samples (fig 4b). Oncogene (2018) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; loading ...; fig 3c
Cell Signaling Technology PTEN antibody (cell signaling, 9559) was used in western blot on mouse samples at 1:1000 (fig 3c). Oncogene (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 2a
  • immunohistochemistry; human; loading ...; fig s6k
In order to understand the interaction between PTEN and FBXL2 in the context of apoptosis, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559S) was used in western blot knockout validation on mouse samples (fig 2a) and in immunohistochemistry on human samples (fig s6k). Nature (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot knockout validation; mouse; loading ...; fig s3a
In order to investigate the interplay among ETS factors in prostate oncogenesis, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot knockout validation on mouse samples (fig s3a). Nature (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 7c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 7c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; loading ...; fig 3a
Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in western blot on mouse samples at 1:1000 (fig 3a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D5G7)
  • western blot; mouse; loading ...; fig 7f
In order to clarify the mechanisms by which miR-21 contributes to oncogenesis, Cell Signaling Technology PTEN antibody (Cell Signaling, 5384S) was used in western blot on mouse samples (fig 7f). Oncogene (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 6a
Cell Signaling Technology PTEN antibody (Cell signaling, 4005) was used in western blot on human samples (fig 6a). Cancer Med (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples (fig 4a). Mol Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1b
In order to observe that chronic presence of internalized Escherichia coli leads to enhanced oncogenicity in colon cancer cells, Cell Signaling Technology PTEN antibody (cell signalling, 9551) was used in western blot on human samples (fig 1b). Cell Death Dis (2017) ncbi
domestic rabbit polyclonal
  • reverse phase protein lysate microarray; human; loading ...; fig st6
In order to characterize the molecular identity of uterine carcinosarcomas., Cell Signaling Technology PTEN antibody (CST, 9552) was used in reverse phase protein lysate microarray on human samples (fig st6). Cancer Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 6e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on mouse samples at 1:1000 (fig 6e). Theranostics (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:500; loading ...; fig 4d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples at 1:500 (fig 4d). Int J Mol Med (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; human; fig s2p
  • western blot; human; loading ...; fig s2e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188S) was used in immunohistochemistry on human samples (fig s2p) and in western blot on human samples (fig s2e). Nature (2017) ncbi
domestic rabbit monoclonal (138G6)
  • immunocytochemistry; rat; 1:500; loading ...; fig 2c
In order to use CRISPR in primary neurons to screen, Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in immunocytochemistry on rat samples at 1:500 (fig 2c). Mol Cell Neurosci (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:2000; loading ...; fig 2d
  • immunocytochemistry; mouse; 1:100; loading ...; fig 3a
  • western blot; mouse; 1:2000; loading ...; fig 2d
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:2000 (fig 2d), in immunocytochemistry on mouse samples at 1:100 (fig 3a) and in western blot on mouse samples at 1:2000 (fig 2d). Nat Commun (2017) ncbi
domestic rabbit monoclonal (44A7)
  • western blot; human; 1:1000; loading ...; fig 2d
  • western blot; mouse; 1:1000; loading ...; fig 2b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9549) was used in western blot on human samples at 1:1000 (fig 2d) and in western blot on mouse samples at 1:1000 (fig 2b). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • immunocytochemistry knockout validation; mouse; 1:300; fig s1a
  • western blot; mouse; 1:2000; fig 1c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunocytochemistry knockout validation on mouse samples at 1:300 (fig s1a) and in western blot on mouse samples at 1:2000 (fig 1c). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 3f
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (fig 3f). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 3f
Cell Signaling Technology PTEN antibody (Cell Signaling, 9551) was used in western blot on human samples at 1:1000 (fig 3f). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to analyze the context specificity of signaling networks within a causal conceptual framework using reverse-phase protein array time-course assays and network analysis approaches, Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9552) was used in western blot on human samples . Cell Syst (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 1d
Cell Signaling Technology PTEN antibody (Cell signaling, 138G6) was used in western blot on human samples (fig 1d). Oncotarget (2017) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Oncotarget (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 2c
  • western blot; human; loading ...; fig 2c
In order to discover that PTEN is a substrate of the ISGylation post-translational modification pathway, Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on mouse samples (fig 2c) and in western blot on human samples (fig 2c). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to discover that PTEN is a substrate of the ISGylation post-translational modification pathway, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Oncotarget (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • immunocytochemistry; human; fig s4b
  • western blot; human; fig 4c
In order to study the mechanisms driving uterine leiomyoma growth and survival via aberrant activation of AKT, Cell Signaling Technology PTEN antibody (Cell signaling, 9188) was used in immunocytochemistry on human samples (fig s4b) and in western blot on human samples (fig 4c). Sci Adv (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 7A
In order to investigate the role of the PTEN phosphatase in DNA interstrand crosslink repair, Cell Signaling Technology PTEN antibody (Cell signaling, 9559) was used in western blot on human samples (fig 7A). Sci Rep (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; loading ...; fig 1e
In order to determine if PIK3CA mutations contribute to tumor initiation, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples (fig 1e). Oncogenesis (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; tbl 1
In order to study the effects of prenatal testosterone on luteinizing hormone secretion in sheep., Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (tbl 1). Endocrinology (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; loading ...; fig 3a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559) was used in western blot on human samples at 1:1000 (fig 3a). Cell Signal (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • immunocytochemistry; mouse; 1:1000; loading ...; fig 1c
In order to identify factors that trigger central nervous system myelination, Cell Signaling Technology PTEN antibody (Cell signaling, 9188) was used in immunocytochemistry on mouse samples at 1:1000 (fig 1c). Nat Neurosci (2017) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 2
In order to elucidate the compartmentalization of p110alpha and p110beta, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 2). elife (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; fig 1
  • western blot knockout validation; human; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples (fig 1) and in western blot knockout validation on human samples (fig 1). Cell Discov (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:200; fig st1
In order to identify and characterize alterations in signal transduction that occur during the development Lapatinib resistance, Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples at 1:200 (fig st1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology PTEN antibody (cell signalling, 9188) was used in western blot on human samples at 1:1000 (fig 3c). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 6b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples (fig 6b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry knockout validation; rat; 1:50; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry knockout validation on rat samples at 1:50 (fig 1). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 6a
In order to analyze pro- and anti-lipolytic signaling pathways in adipocytes after in vivo endotoxin exposure, Cell Signaling Technology PTEN antibody (Cell signaling, 9188) was used in western blot on human samples (fig 6a). PLoS ONE (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:2000; fig 5
In order to determine PTP family expression in diffuse glioma subtypes, Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559) was used in western blot on human samples at 1:2000 (fig 5). Acta Neuropathol Commun (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 6n
In order to demonstrate that mice with adipocyte-specific activation of Notch signaling develop liposarcomas with complete penetrance, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 6n). J Exp Med (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 5a
In order to show that pituitary tumor transforming gene 1 expression is upregulated in an mammalian/mechanistic target of rapamycin complex 1-dependent manner, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot knockout validation on mouse samples (fig 5a). Oncogene (2017) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; fig 3
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples at 1:1000 (fig 3). Nat Commun (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig s3c
In order to elucidate how Cdh1 regulates NEDD4 family E3 ligases such as WWP2, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig s3c). Cell Discov (2016) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; human; fig 1a
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry on human samples (fig 1a). Oncotarget (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 4e
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 4e). Cancer Sci (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 3
In order to identify and characterize two non-AUG-initiated PTEN proteoforms, Cell Signaling Technology PTEN antibody (Cell Signalling, 138G6) was used in western blot on human samples (fig 3). Open Biol (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig s6
Cell Signaling Technology PTEN antibody (Cell Signaling, 9551) was used in western blot on mouse samples (fig s6). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig s3
  • immunoprecipitation; mouse; fig 2
  • western blot; mouse; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559L) was used in western blot on human samples (fig s3), in immunoprecipitation on mouse samples (fig 2) and in western blot on mouse samples (fig 1). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 6a
In order to investigate the role of growth hormone in colon cancer, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 6a). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000; fig 5
In order to investigate inhibition of neural stem cell proliferation through Wnt/beta-catenin pathway by its GAP domain via Porf-2, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188s) was used in western blot on mouse samples at 1:1000 (fig 5). Front Cell Neurosci (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; fig 5
In order to investigate inhibition of neural stem cell proliferation through Wnt/beta-catenin pathway by its GAP domain via Porf-2, Cell Signaling Technology PTEN antibody (Cell Signaling, 9554s) was used in western blot on mouse samples at 1:1000 (fig 5). Front Cell Neurosci (2016) ncbi
domestic rabbit monoclonal (44A7)
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology PTEN antibody (Cell Signaling Technologies, 9549) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; fig s1
Cell Signaling Technology PTEN antibody (Cell Signaling Technologies, 9559) was used in western blot on human samples at 1:1000 (fig s1). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig s2b
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9552) was used in western blot on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to assess PTEN expression by immunopathology, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Methods Mol Biol (2016) ncbi
mouse monoclonal (26H9)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to assess PTEN expression by immunopathology, Cell Signaling Technology PTEN antibody (Cell Signaling, 9556) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Methods Mol Biol (2016) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; human; tbl 1
  • western blot; human; fig 1
In order to assess PTEN expression by immunopathology, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry - paraffin section on human samples (tbl 1) and in western blot on human samples (fig 1). Methods Mol Biol (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; loading ...; fig 4
In order to find tumor types sensitive to phosphoinositide 3-kinase pathway inhibitors, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples (fig 4). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
In order to determine how inhibition of human glioblastoma invasion by actin polymerization can occur by an anti-depressant called fluvoxamine, Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9551) was used in western blot on human samples (fig 5). Sci Rep (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; fig 7
In order to study promotion of invasion, migration and anti-apoptosis in gastric cancer and the role of HOXB7, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples at 1:1000 (fig 7). J Gastroenterol Hepatol (2016) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; human; 1:200; fig s1
In order to utilize ovarian cancer xenograft models to study dynamic modulation of phosphoprotein expression, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s1). BMC Cancer (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; mouse; 1:125; fig 1
  • western blot; mouse; 1:1000; fig 5
Cell Signaling Technology PTEN antibody (Cell signaling, 9188) was used in immunohistochemistry - paraffin section on mouse samples at 1:125 (fig 1) and in western blot on mouse samples at 1:1000 (fig 5). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology PTEN antibody (Cell Signaling, 9554) was used in western blot on human samples (fig 4). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; human; fig 6
  • western blot; human; 1:1000; fig 6
Cell Signaling Technology PTEN antibody (Cell Signalling, 9188) was used in immunohistochemistry - paraffin section on human samples (fig 6) and in western blot on human samples at 1:1000 (fig 6). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s3
In order to investigate the role of topoisomerase IIbeta-binding protein 1 in DNA repair and its contribution to cancer, Cell Signaling Technology PTEN antibody (Cell Signaling, 9551) was used in western blot on human samples (fig s3). J Cell Biol (2016) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 4b
In order to study 3-bromopyruvate, human colorectal cancer cells, glucose concentration, and hexokinase II expression, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (fig 4b). Biosci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000
In order to determine the mechanisms of resistance to the pan-HER family inhibitor AZD8931, Cell Signaling Technology PTEN antibody (Cell Signaling, 9552) was used in western blot on human samples at 1:1000. Dis Model Mech (2016) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 6
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples (fig 6). Front Genet (2015) ncbi
domestic rabbit monoclonal (138G6)
  • chromatin immunoprecipitation; human; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in chromatin immunoprecipitation on human samples (fig 1). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000; fig 3
In order to test if GATA5 is a regulator of blood pressure, Cell Signaling Technology PTEN antibody (Cell Signalling, 9188) was used in western blot on mouse samples at 1:1000 (fig 3). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; loading ...; fig 8b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 8b). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; human
  • western blot; human
Cell Signaling Technology PTEN antibody (CST, 9188) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples . Nature (2015) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry knockout validation; rat; 1:50; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry knockout validation on rat samples at 1:50 (fig 1). Development (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000; fig s7d
Cell Signaling Technology PTEN antibody (Cell Signaling technologies, 9188) was used in western blot on mouse samples at 1:1000 (fig s7d). Nat Med (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; human; 1:50; loading ...; fig 2a
Cell Signaling Technology PTEN antibody (Cell Signaling, D4.3) was used in immunohistochemistry on human samples at 1:50 (fig 2a). J Pathol (2016) ncbi
domestic rabbit monoclonal (138G6)
  • immunoprecipitation; human; 1:50; fig 2c
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunoprecipitation on human samples at 1:50 (fig 2c). Nat Commun (2015) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; 1:1000; fig 1c
Cell Signaling Technology PTEN antibody (Cell Signalin, 9559) was used in western blot on human samples at 1:1000 (fig 1c). Nat Commun (2015) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig 1
Cell Signaling Technology PTEN antibody (Cell Signalling, 9559) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 1). PLoS ONE (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 2a
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on human samples (fig 2a). Oncogene (2016) ncbi
domestic rabbit monoclonal (44A7)
  • western blot; mouse; fig 5
Cell Signaling Technology PTEN antibody (Cell Signaling, 9549S) was used in western blot on mouse samples (fig 5). Am J Physiol Renal Physiol (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; mouse; 1:200
In order to study mitochondrial dynamics and morphology in myelinating Schwann cells in living mice, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry on mouse samples at 1:200. Mitochondrion (2015) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 3
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559S) was used in western blot on human samples (fig 3). Mol Cancer Res (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; rat; 1:2000
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on rat samples at 1:2000. Exp Neurol (2015) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry - paraffin section; mouse; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry - paraffin section on mouse samples (fig 1). Cancer Res (2015) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 3
In order to characterize human solid salivary adenoid cystic carcinoma and high frequency of loss of PTEN expression as a targeted therapy, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on human samples (fig 3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; fig 5
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples at 1:1000 (fig 5). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; fig s1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in western blot on mouse samples at 1:1000 (fig s1). Cell (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - free floating section; mouse; 1:250
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188S) was used in immunohistochemistry - free floating section on mouse samples at 1:250. Exp Neurol (2015) ncbi
domestic rabbit monoclonal (138G6)
  • immunocytochemistry; human; 1:200; fig 2
  • western blot; human; fig 2
Cell Signaling Technology PTEN antibody (Cell signaling, 9559) was used in immunocytochemistry on human samples at 1:200 (fig 2) and in western blot on human samples (fig 2). Methods (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; mouse; 1:50
  • western blot; mouse; 1:5000
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry on mouse samples at 1:50 and in western blot on mouse samples at 1:5000. Endocrinology (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples (fig 1). Breast Cancer Res (2015) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; fig s7
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 138D6) was used in western blot on mouse samples (fig s7). Nat Immunol (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; human; fig 1a
In order to discuss the limitations of c-Kit/PDGFR-targeted therapies for treatment of gastrointestinal stromal tumors, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry on human samples (fig 1a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6
Cell Signaling Technology PTEN antibody (Cell signaling, 9188S) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6). Cancer Biol Ther (2014) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; human; tbl 2
In order to use endometrial carcinoma as a three-dimensional model to study PTEN deficiency, Cell Signaling Technology PTEN antibody (Cell Signaling, 9559) was used in immunohistochemistry on human samples (tbl 2). Methods (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; human; tbl 2
In order to use endometrial carcinoma as a three-dimensional model to study PTEN deficiency, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry on human samples (tbl 2). Methods (2015) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000 (fig 2b). Mol Oncol (2015) ncbi
domestic rabbit monoclonal (138G6)
  • immunoprecipitation; human; fig 3
  • western blot; human; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 138G6) was used in immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 1). J Neurosci (2014) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; 1:1000
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples at 1:1000. Cell (2014) ncbi
domestic rabbit monoclonal (44A7)
  • western blot; human
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9549) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human; fig 3
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on human samples (fig 3). PLoS ONE (2014) ncbi
domestic rabbit monoclonal (138G6)
  • immunoprecipitation; human
  • immunocytochemistry; human; 1:200; fig 2
  • western blot; human; fig 2
In order to present a mechanism for the N-myc downstream-regulated gene 2-dependent regulation of PTEN phosphatase activity via the dephosphorylation of PTEN, Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 138G6) was used in immunoprecipitation on human samples , in immunocytochemistry on human samples at 1:200 (fig 2) and in western blot on human samples (fig 2). Nat Commun (2014) ncbi
mouse monoclonal (26H9)
  • immunoprecipitation; human; 1:100
  • western blot; human; fig 2
In order to present a mechanism for the N-myc downstream-regulated gene 2-dependent regulation of PTEN phosphatase activity via the dephosphorylation of PTEN, Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 26H9) was used in immunoprecipitation on human samples at 1:100 and in western blot on human samples (fig 2). Nat Commun (2014) ncbi
domestic rabbit monoclonal (138G6)
  • western blot knockout validation; mouse; loading ...; fig 9b
Cell Signaling Technology PTEN antibody (Cell signaling, 9559) was used in western blot knockout validation on mouse samples (fig 9b). Mol Cell Biol (2014) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - paraffin section; human
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry - paraffin section on human samples . Leukemia (2014) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry - free floating section; mouse; 1:400
In order to describe the synaptic changes in neurons lacking PTEN, Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in immunohistochemistry - free floating section on mouse samples at 1:400. J Comp Neurol (2014) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; human
Cell Signaling Technology PTEN antibody (Cell Signaling, 9188) was used in western blot on human samples . Mol Cancer Ther (2014) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; mouse; 1:1000; fig 6
Cell Signaling Technology PTEN antibody (Cell Signaling, #9559) was used in western blot on mouse samples at 1:1000 (fig 6). Int J Cancer (2014) ncbi
domestic rabbit monoclonal (138G6)
  • western blot; human; fig 1
Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in western blot on human samples (fig 1). Cancer Res (2013) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:500
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9188) was used in western blot on mouse samples at 1:500. PLoS ONE (2013) ncbi
domestic rabbit monoclonal (D4.3)
  • western blot; mouse; 1:1000
Cell Signaling Technology PTEN antibody (Cell Signaling, D4.3) was used in western blot on mouse samples at 1:1000. Carcinogenesis (2013) ncbi
domestic rabbit monoclonal (D4.3)
  • immunohistochemistry; human; 1:50
Cell Signaling Technology PTEN antibody (Cell Signaling Technologies, 9188) was used in immunohistochemistry on human samples at 1:50. Mod Pathol (2013) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry; mouse; 1:500
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 9559) was used in immunohistochemistry on mouse samples at 1:500. Fibrogenesis Tissue Repair (2012) ncbi
mouse monoclonal (26H9)
  • immunocytochemistry; human; 1:100
  • western blot; human
Cell Signaling Technology PTEN antibody (Cell Signaling Technology, 26H9) was used in immunocytochemistry on human samples at 1:100 and in western blot on human samples . Breast Cancer Res (2011) ncbi
domestic rabbit monoclonal (138G6)
  • immunohistochemistry knockout validation; mouse; fig 3
In order to investigate the influence of PTEN on prostate adenocarcinoma development and its mechanism, Cell Signaling Technology PTEN antibody (Cell Signaling, 138G6) was used in immunohistochemistry knockout validation on mouse samples (fig 3). Am J Pathol (2009) ncbi
Dako
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig s7f
Dako PTEN antibody (Dako, M3627) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig s7f). Mol Cell (2017) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
Dako PTEN antibody (Dako, 6H2.1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Oncotarget (2017) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
Dako PTEN antibody (Dako, M3627) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). Oncotarget (2016) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; tbl 1
In order to assess PTEN expression by immunopathology, Dako PTEN antibody (Dako, M3627) was used in immunohistochemistry - paraffin section on human samples (tbl 1). Methods Mol Biol (2016) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; 1:50; fig 2
In order to study clear cell renal cell carcinoma and snail heterogeneity, Dako PTEN antibody (Dako, M3627) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 2). BMC Cancer (2016) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2
In order to correlate expression of proteins in ErbB family signaling pathways with the clinical efficacy of lapatinib, Dako PTEN antibody (DAKO, 6H2.1) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Oncotarget (2016) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; human; 1:100; loading ...; fig 3g
Dako PTEN antibody (DAKO, 6H2.1) was used in immunohistochemistry on human samples at 1:100 (fig 3g). Nat Commun (2015) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; human; 1:100
In order to evaluate expression of receptor tyrosine kinases, their ligands, and mutational status and correlate with features observed in solitary fibrous tumors, Dako PTEN antibody (Dako, M3627) was used in immunohistochemistry on human samples at 1:100. Hum Pathol (2015) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; human; 1:100
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, Dako PTEN antibody (Dako, 6H2.1) was used in immunohistochemistry on human samples at 1:100. Gynecol Oncol (2015) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; 1:100
Dako PTEN antibody (DAKO, 6H2.1) was used in immunohistochemistry - paraffin section on human samples at 1:100. J Neuroimmunol (2014) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; human; tbl 2
In order to use endometrial carcinoma as a three-dimensional model to study PTEN deficiency, Dako PTEN antibody (DAKO, M3627) was used in immunohistochemistry on human samples (tbl 2). Methods (2015) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; human; 1:100
Dako PTEN antibody (Dako, 6H2.1) was used in immunohistochemistry on human samples at 1:100. Anticancer Res (2014) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; mouse
Dako PTEN antibody (DAKO, 6H2.1) was used in immunohistochemistry on mouse samples . Head Neck (2015) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry; human
In order to enhance our understanding of Brca2, Pten and p53 in breast cancer development, Dako PTEN antibody (Dako, 6H2.1) was used in immunohistochemistry on human samples . J Pathol (2014) ncbi
mouse monoclonal (6H2.1)
  • immunohistochemistry - paraffin section; human; 1:150
Dako PTEN antibody (DAKO, M3627) was used in immunohistochemistry - paraffin section on human samples at 1:150. Acta Histochem (2014) ncbi
BD Biosciences
mouse monoclonal (A2b1)
  • flow cytometry; mouse; loading ...; fig 4d
BD Biosciences PTEN antibody (BD Biosciences, 560002) was used in flow cytometry on mouse samples (fig 4d). J Immunol (2022) ncbi
mouse monoclonal (A2b1)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences PTEN antibody (BD, A2B1) was used in flow cytometry on mouse samples (fig 3b). J Exp Med (2017) ncbi
mouse monoclonal (A2b1)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BD Biosciences PTEN antibody (BD, A2B1) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (A2b1)
  • flow cytometry; human; 1:5; fig s2a
BD Biosciences PTEN antibody (BD, 560002) was used in flow cytometry on human samples at 1:5 (fig s2a). Nat Med (2015) ncbi
mouse monoclonal (A2b1)
  • flow cytometry; mouse; fig s1
In order to show that the PTEN-mTORC2 axis maintains T regulatory cell stability and coordinates their control of effector responses, BD Biosciences PTEN antibody (BD Biosciences, A2B1) was used in flow cytometry on mouse samples (fig s1). Nat Immunol (2015) ncbi
mouse monoclonal (A2b1)
  • immunohistochemistry - frozen section; mouse; 1:20
BD Biosciences PTEN antibody (BD Biosciences, 560002) was used in immunohistochemistry - frozen section on mouse samples at 1:20. PLoS ONE (2013) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • immunocytochemistry; human; fig s3
  • western blot; human; 1:1000; fig 6
MilliporeSigma PTEN antibody (Sigma, SAB4300336) was used in immunocytochemistry on human samples (fig s3) and in western blot on human samples at 1:1000 (fig 6). Sci Rep (2016) ncbi
Articles Reviewed
  1. Pan R, Yu Y, Zhu H, Zhang W, Qin Y, Ye L, et al. RSPO2 promotes progression of ovarian cancer through dual receptor-mediated FAK/Src signaling activation. iScience. 2022;25:105184 pubmed publisher
  2. Chen F, Xiao M, Feng J, Wufur R, Liu K, Hu S, et al. Different Inhibition of Nrf2 by Two Keap1 Isoforms α and β to Shape Malignant Behaviour of Human Hepatocellular Carcinoma. Int J Mol Sci. 2022;23: pubmed publisher
  3. Amen A, Loughran R, Huang C, Lew R, Ravi A, Guan Y, et al. Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi. Cell Rep Methods. 2022;2:100239 pubmed publisher
  4. Zhang R, Ai J, Wang J, Sun C, Lu H, He A, et al. NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN. J Transl Med. 2022;20:325 pubmed publisher
  5. Wu T, Wang W, Shi G, Hao M, Wang Y, Yao M, et al. Targeting HIC1/TGF-β axis-shaped prostate cancer microenvironment restrains its progression. Cell Death Dis. 2022;13:624 pubmed publisher
  6. Chen Y, Xu J, Pan W, Xu X, Ma X, Chu Y, et al. Galectin-3 enhances trastuzumab resistance by regulating cancer malignancy and stemness in HER2-positive breast cancer cells. Thorac Cancer. 2022;13:1961-1973 pubmed publisher
  7. Fernandes H, Zonnari A, Abreu R, Aday S, Bar xe3 o M, Albino I, et al. Extracellular vesicles enriched with an endothelial cell pro-survival microRNA affects skin tissue regeneration. Mol Ther Nucleic Acids. 2022;28:307-327 pubmed publisher
  8. Wemlinger S, Parker Harp C, Yu B, Hardy I, Seefeldt M, Matsuda J, et al. Preclinical Analysis of Candidate Anti-Human CD79 Therapeutic Antibodies Using a Humanized CD79 Mouse Model. J Immunol. 2022;208:1566-1584 pubmed publisher
  9. Hsiao Y, Chi J, Li C, Chen L, Chen Y, Liang H, et al. Disruption of the pentraxin 3/CD44 interaction as an efficient therapy for triple-negative breast cancers. Clin Transl Med. 2022;12:e724 pubmed publisher
  10. Xia R, Liu T, Li W, Xu X. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA. Clin Transl Med. 2021;11:e383 pubmed publisher
  11. Lin G, Li J, Cai J, Zhang H, Xin Q, Wang N, et al. RNA-binding Protein MBNL2 regulates Cancer Cell Metastasis through MiR-182-MBNL2-AKT Pathway. J Cancer. 2021;12:6715-6726 pubmed publisher
  12. Ning J, Chu C, Du Y, Zuo L. MiR-25 regulates cell proliferation and metastasis in bladder urothelial carcinoma. J Cancer. 2021;12:6706-6714 pubmed publisher
  13. Cheng F, Cheng Y, Zhao X, An L, Yang L, Li Z, et al. NEDD4 E3 ubiquitin protein ligase serves an important role in cutaneous melanoma occurrence and development. Exp Ther Med. 2021;22:1382 pubmed publisher
  14. Eritja N, Navaridas R, Ruiz Mitjana A, Vidal Sabanés M, Egea J, Encinas M, et al. Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation. Cancers (Basel). 2021;13: pubmed publisher
  15. Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clement S, Maeder C, et al. Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers (Basel). 2021;13: pubmed publisher
  16. Ali A, Kuo W, Kuo C, Lo J, Chen M, Daddam J, et al. E3 ligase activity of Carboxyl terminus of Hsc70 interacting protein (CHIP) in Wharton's jelly derived mesenchymal stem cells improves their persistence under hyperglycemic stress and promotes the prophylactic effects against diabetic cardiac damages. Bioeng Transl Med. 2021;6:e10234 pubmed publisher
  17. Langdon C, Gadek K, Garcia M, Evans M, Reed K, Bush M, et al. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity. Nat Commun. 2021;12:5520 pubmed publisher
  18. Chen Q, Fan K, Chen X, Xie X, Huang L, Song G, et al. Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling. J Cell Mol Med. 2021;25:9378-9389 pubmed publisher
  19. Xiao X, Li W, Rong D, Xu Z, Zhang Z, Ye H, et al. Human umbilical cord mesenchymal stem cells-derived extracellular vesicles facilitate the repair of spinal cord injury via the miR-29b-3p/PTEN/Akt/mTOR axis. Cell Death Discov. 2021;7:212 pubmed publisher
  20. Feng W, Cao Z, Lim P, Zhao H, Luo H, Mao N, et al. Rapid interrogation of cancer cell of origin through CRISPR editing. Proc Natl Acad Sci U S A. 2021;118: pubmed publisher
  21. Guo E, Mao X, Wang X, Guo L, An C, Zhang C, et al. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma. Cell Death Dis. 2021;12:764 pubmed publisher
  22. Mygland L, Brinch S, Strand M, Olsen P, Aizenshtadt A, Lund K, et al. Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines. iScience. 2021;24:102807 pubmed publisher
  23. Chai A, Chen X, Xu X, Zhang N, Li M, Li J, et al. A Temporal Activity of CA1 Neurons Underlying Short-Term Memory for Social Recognition Altered in PTEN Mouse Models of Autism Spectrum Disorder. Front Cell Neurosci. 2021;15:699315 pubmed publisher
  24. Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed publisher
  25. Wang W, Lu G, Liu H, Xiong Z, Leung H, Cao R, et al. Pten Regulates Cardiomyocyte Differentiation by Modulating Non-CG Methylation via Dnmt3. Adv Sci (Weinh). 2021;:e2100849 pubmed publisher
  26. Zoma M, Curti L, Shinde D, Albino D, Mitra A, Sgrignani J, et al. EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer. Nat Commun. 2021;12:4147 pubmed publisher
  27. Ning J, He K, Cheng F, Li W, Yu W, Li H, et al. Long Non-coding RNA MEG3 Promotes Pyroptosis in Testicular Ischemia-Reperfusion Injury by Targeting MiR-29a to Modulate PTEN Expression. Front Cell Dev Biol. 2021;9:671613 pubmed publisher
  28. Pham Q, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, et al. Clinicopathologic features of TDO2 overexpression in renal cell carcinoma. BMC Cancer. 2021;21:737 pubmed publisher
  29. Hamm M, Sohier P, Petit V, Raymond J, Delmas V, Le Coz M, et al. BRN2 is a non-canonical melanoma tumor-suppressor. Nat Commun. 2021;12:3707 pubmed publisher
  30. Tan H, Song Y, Chen J, Zhang N, Wang Q, Li Q, et al. Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury. Adv Sci (Weinh). 2021;8:e2100787 pubmed publisher
  31. Brady N, Bagadion A, Singh R, Conteduca V, Van Emmenis L, Arceci E, et al. Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer. Nat Commun. 2021;12:3372 pubmed publisher
  32. Diaz González M, Buberman A, Morales M, Ferrer I, Knafo S. Aberrant Synaptic PTEN in Symptomatic Alzheimer's Patients May Link Synaptic Depression to Network Failure. Front Synaptic Neurosci. 2021;13:683290 pubmed publisher
  33. Tamura T, Kodama T, Sato K, Murai K, Yoshioka T, Shigekawa M, et al. Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation. J Clin Invest. 2021;131: pubmed publisher
  34. Han B, Sun Z, Yu T, Wang Y, Kuang L, Li T, et al. SPOP-PTEN-SUFU axis promotes progression of clear cell renal cell carcinoma via activating SHH and WNT pathway. Cell Death Discov. 2021;7:120 pubmed publisher
  35. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  36. Hewa Bostanthirige D, Komaragiri S, Joshi J, Alzahrani M, Saini I, Jain S, et al. The helix-loop-helix transcriptional regulator Id4 is required for terminal differentiation of luminal epithelial cells in the prostate. Oncoscience. 2021;8:14-30 pubmed publisher
  37. Gangoso E, Southgate B, Bradley L, Rus S, Gálvez Cancino F, McGivern N, et al. Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion. Cell. 2021;184:2454-2470.e26 pubmed publisher
  38. Li H, Liu Y, Jiang W, Xue J, Cheng Y, Wang J, et al. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma. BMC Cancer. 2021;21:318 pubmed publisher
  39. Lai C, Yeh K, Lin C, Hsieh Y, Lai H, Chen J, et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers (Basel). 2021;13: pubmed publisher
  40. Tian M, Wang J, Liu S, Li X, Li J, Yang J, et al. Hepatic HuR protects against the pathogenesis of non-alcoholic fatty liver disease by targeting PTEN. Cell Death Dis. 2021;12:236 pubmed publisher
  41. Wan X, Zhou M, Huang F, Zhao N, Chen X, Wu Y, et al. AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development. Cell Death Dis. 2021;12:172 pubmed publisher
  42. Feiner L, Tierling S, Holländer S, Glanemann M, Rubie C. An aging and p53 related marker: HOXA5 promoter methylation negatively correlates with mRNA and protein expression in old age. Aging (Albany NY). 2021;13:4831-4849 pubmed publisher
  43. Xu Y, Zhang Y, Liang H, Liu X. Coumestrol mitigates retinal cell inflammation, apoptosis, and oxidative stress in a rat model of diabetic retinopathy via activation of SIRT1. Aging (Albany NY). 2021;13:5342-5357 pubmed publisher
  44. Lin J, Zhu H, Hong L, Tang W, Wang J, Hu H, et al. Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer. Aging (Albany NY). 2021;13:6606-6624 pubmed publisher
  45. He S, Zhang H, Lu Y, Zhang Z, Zhang X, Zhou N, et al. Nampt promotes osteogenic differentiation and lipopolysaccharide-induced interleukin-6 secretion in osteoblastic MC3T3-E1 cells. Aging (Albany NY). 2021;13:5150-5163 pubmed publisher
  46. Bae M, Roh J, Kim Y, Kim S, Han H, Yang E, et al. SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. EMBO Mol Med. 2021;13:e12632 pubmed publisher
  47. Wang H, Radomska H, Phelps M, Iorns E, Tsui R, Denis A, et al. Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. elife. 2020;9: pubmed publisher
  48. Tan Y, Sementino E, Liu Z, Cai K, Testa J. Wnt signaling mediates oncogenic synergy between Akt and Dlx5 in T-cell lymphomagenesis by enhancing cholesterol synthesis. Sci Rep. 2020;10:15837 pubmed publisher
  49. Brunner A, Suryo Rahmanto A, Johansson H, Franco M, Viiliäinen J, Gazi M, et al. PTEN and DNA-PK determine sensitivity and recovery in response to WEE1 inhibition in human breast cancer. elife. 2020;9: pubmed publisher
  50. Kerwin J, Khan I, Iorns E, Tsui R, Denis A, Perfito N, et al. Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. elife. 2020;9: pubmed publisher
  51. Alajati A, D Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, et al. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. J Clin Invest. 2020;130:2435-2450 pubmed publisher
  52. Hermanova I, Z iga Garc a P, Caro Maldonado A, Fernandez Ruiz S, Salvador F, Mart n Mart n N, et al. Genetic manipulation of LKB1 elicits lethal metastatic prostate cancer. J Exp Med. 2020;217: pubmed publisher
  53. Negrón A, Yu G, Boehm U, Acosta Martinez M. Targeted Deletion of PTEN in Kisspeptin Cells Results in Brain Region- and Sex-Specific Effects on Kisspeptin Expression and Gonadotropin Release. Int J Mol Sci. 2020;21: pubmed publisher
  54. Wu W, Jing D, Meng Z, Hu B, Zhong B, Deng X, et al. FGD1 promotes tumor progression and regulates tumor immune response in osteosarcoma via inhibiting PTEN activity. Theranostics. 2020;10:2859-2871 pubmed publisher
  55. Funada K, Yoshizaki K, Miyazaki K, Han X, Yuta T, Tian T, et al. microRNA-875-5p plays critical role for mesenchymal condensation in epithelial-mesenchymal interaction during tooth development. Sci Rep. 2020;10:4918 pubmed publisher
  56. Li J, Zhang W, Zhu S, Shi F. Nitric Oxide Synthase Is Involved in Follicular Development via the PI3K/AKT/FoxO3a Pathway in Neonatal and Immature Rats. Animals (Basel). 2020;10: pubmed publisher
  57. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed publisher
  58. Liu Z, Wen J, Wu C, Hu C, Wang J, Bao Q, et al. MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma. Aging (Albany NY). 2020;12:1213-1236 pubmed publisher
  59. Gugel I, Ebner F, Grimm F, Czemmel S, Paulsen F, Hagel C, et al. Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis. Cancers (Basel). 2020;12: pubmed publisher
  60. Delev D, Daka K, Heynckes S, Gaebelein A, Franco P, Pfeifer D, et al. Long-term epilepsy-associated tumors: transcriptional signatures reflect clinical course. Sci Rep. 2020;10:96 pubmed publisher
  61. Wei J, Long L, Zheng W, Dhungana Y, Lim S, Guy C, et al. Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy. Nature. 2019;576:471-476 pubmed publisher
  62. Li N, Men W, Zheng Y, Wang H, Meng X. Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer. Molecules. 2019;24: pubmed publisher
  63. Wall C, Rose C, Adrian M, Zeng Y, Kirkpatrick D, Bingol B. PPEF2 Opposes PINK1-Mediated Mitochondrial Quality Control by Dephosphorylating Ubiquitin. Cell Rep. 2019;29:3280-3292.e7 pubmed publisher
  64. Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10:5492 pubmed publisher
  65. Ghezzi C, Wong A, Chen B, Ribalet B, Damoiseaux R, Clark P. A high-throughput screen identifies that CDK7 activates glucose consumption in lung cancer cells. Nat Commun. 2019;10:5444 pubmed publisher
  66. Brosig A, Fuchs J, Ipek F, Kroon C, Schrötter S, Vadhvani M, et al. The Axonal Membrane Protein PRG2 Inhibits PTEN and Directs Growth to Branches. Cell Rep. 2019;29:2028-2040.e8 pubmed publisher
  67. Tracey N, Creedon H, Kemp A, Culley J, Muir M, Klinowska T, et al. HO-1 drives autophagy as a mechanism of resistance against HER2-targeted therapies. Breast Cancer Res Treat. 2020;179:543-555 pubmed publisher
  68. Ali R, Alabdullah M, Miligy I, Normatova M, Babaei Jadidi R, Nateri A, et al. ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity. Cells. 2019;8: pubmed publisher
  69. Veschi V, Mangiapane L, Nicotra A, Di Franco S, Scavo E, Apuzzo T, et al. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant. Oncogene. 2020;39:987-1003 pubmed publisher
  70. McMahon M, Contreras A, Holm M, Uechi T, Forester C, Pang X, et al. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS. elife. 2019;8: pubmed publisher
  71. Mao N, Gao D, Hu W, Hieronymus H, Wang S, Lee Y, et al. Aberrant Expression of ERG Promotes Resistance to Combined PI3K and AR Pathway Inhibition through Maintenance of AR Target Genes. Mol Cancer Ther. 2019;18:1577-1586 pubmed publisher
  72. Du T, Li H, Fan Y, Yuan L, Guo X, Zhu Q, et al. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. Nat Commun. 2019;10:2914 pubmed publisher
  73. Adams E, Karthaus W, Hoover E, Liu D, Gruet A, Zhang Z, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571:408-412 pubmed publisher
  74. Lu Q, Liu T, Feng H, Yang R, Zhao X, Chen W, et al. Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 2019;18:111 pubmed publisher
  75. Zhang J, Lee Y, Dang F, Gan W, Menon A, Katon J, et al. PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage. Cancer Discov. 2019;: pubmed publisher
  76. Chen P, Zhao D, Li J, Liang X, Li J, Chang A, et al. Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma. Cancer Cell. 2019;35:868-884.e6 pubmed publisher
  77. Lee Y, Chen M, Lee J, Zhang J, Lin S, Fu T, et al. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway. Science. 2019;364: pubmed publisher
  78. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  79. Gao L, Hu Y, Tian Y, Fan Z, Wang K, Li H, et al. Lung cancer deficient in the tumor suppressor GATA4 is sensitive to TGFBR1 inhibition. Nat Commun. 2019;10:1665 pubmed publisher
  80. Zhu M, Lu T, Jia Y, Luo X, Gopal P, Li L, et al. Somatic Mutations Increase Hepatic Clonal Fitness and Regeneration in Chronic Liver Disease. Cell. 2019;177:608-621.e12 pubmed publisher
  81. Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, et al. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Gut. 2020;69:177-186 pubmed publisher
  82. Shen T, Li H, Song Y, Li L, Lin J, Wei G, et al. Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence. Aging (Albany NY). 2019;11:1356-1388 pubmed publisher
  83. Li Y, Hu Q, Li C, Liang K, Xiang Y, Hsiao H, et al. PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest. 2019;129:1129-1151 pubmed publisher
  84. Wang W, Shen T, Dong B, Creighton C, Meng Y, Zhou W, et al. MAPK4 overexpression promotes tumor progression via noncanonical activation of AKT/mTOR signaling. J Clin Invest. 2019;: pubmed publisher
  85. Qiu L, Wang M, Hu S, Ru X, Ren Y, Zhang Z, et al. Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor Repressor. Cancers (Basel). 2018;10: pubmed publisher
  86. Bitar M, Nader J, Al Ali W, Al Madhoun A, Arefanian H, Al Mulla F. Hydrogen Sulfide Donor NaHS Improves Metabolism and Reduces Muscle Atrophy in Type 2 Diabetes: Implication for Understanding Sarcopenic Pathophysiology. Oxid Med Cell Longev. 2018;2018:6825452 pubmed publisher
  87. Ding Y, Li N, Dong B, Guo W, Wei H, Chen Q, et al. Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer. J Clin Invest. 2019;129:759-773 pubmed publisher
  88. Kim C, Hu B, Jadhav R, Jin J, Zhang H, Cavanagh M, et al. Activation of miR-21-Regulated Pathways in Immune Aging Selects against Signatures Characteristic of Memory T Cells. Cell Rep. 2018;25:2148-2162.e5 pubmed publisher
  89. Chen C, Zou L, Lin Q, Yan X, Bi H, Xie X, et al. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biol. 2019;20:390-401 pubmed publisher
  90. Zhang M, Suarez E, Vasquez J, Nathanson L, Peterson L, Rajapakshe K, et al. Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity. Oncogene. 2019;38:1121-1135 pubmed publisher
  91. Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt F, Liniany L, Knight D, et al. PD-1 Inhibitory Receptor Downregulates Asparaginyl Endopeptidase and Maintains Foxp3 Transcription Factor Stability in Induced Regulatory T Cells. Immunity. 2018;49:247-263.e7 pubmed publisher
  92. Li R, Sahu S, Schachner M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor Neurol Neurosci. 2018;36:469-483 pubmed publisher
  93. Anker J, Naseem A, Mok H, Schaeffer A, Abdulkadir S, Thumbikat P. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy. Nat Commun. 2018;9:1591 pubmed publisher
  94. Li H, Zhang P, Zhang Q, Li C, Zou W, Chang Z, et al. WWP2 is a physiological ubiquitin ligase for phosphatase and tensin homolog (PTEN) in mice. J Biol Chem. 2018;293:8886-8899 pubmed publisher
  95. Mirzamohammadi F, Kozlova A, Papaioannou G, Paltrinieri E, Ayturk U, Kobayashi T. Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models. Nat Commun. 2018;9:1352 pubmed publisher
  96. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  97. Nan H, Han L, Ma J, Yang C, Su R, He J. STX3 represses the stability of the tumor suppressor PTEN to activate the PI3K-Akt-mTOR signaling and promotes the growth of breast cancer cells. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1684-1692 pubmed publisher
  98. Chang J, Tang N, Fang Q, Zhu K, Liu L, Xiong X, et al. TEMPORARY REMOVAL: Inhibition of COX-2 and 5-LOX regulates the progression of colorectal cancer by promoting PTEN and suppressing PI3K/AKT pathway. Biochem Biophys Res Commun. 2018;: pubmed publisher
  99. Zhang S, Zhang M, Jing Y, Yin X, Ma P, Zhang Z, et al. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nat Commun. 2018;9:215 pubmed publisher
  100. Oldrini B, Hsieh W, Erdjument Bromage H, Codega P, Carro M, Curiel García A, et al. EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer. Nat Commun. 2017;8:2035 pubmed publisher
  101. Vu L, Pickering B, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369-1376 pubmed publisher
  102. Comiskey D, Jacob A, Sanford B, Montes M, Goodwin A, Steiner H, et al. A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. Oncogene. 2018;37:95-106 pubmed publisher
  103. Simond A, Rao T, Zuo D, Zhao J, Muller W. ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor. Oncogene. 2017;36:6059-6066 pubmed publisher
  104. Li M, Cheng W, Luo J, Hu X, Nie T, Lai H, et al. Loss of selenocysteine insertion sequence binding protein 2 suppresses the proliferation, migration/invasion and hormone secretion of human trophoblast cells via the PI3K/Akt and ERK signaling pathway. Placenta. 2017;55:81-89 pubmed publisher
  105. Kuchay S, Giorgi C, Simoneschi D, Pagan J, Missiroli S, Saraf A, et al. PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth. Nature. 2017;546:554-558 pubmed publisher
  106. Bose R, Karthaus W, Armenia J, Abida W, Iaquinta P, Zhang Z, et al. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis. Nature. 2017;546:671-675 pubmed publisher
  107. Kapil S, Sharma B, Patil M, Elattar S, Yuan J, Hou S, et al. The cell polarity protein Scrib functions as a tumor suppressor in liver cancer. Oncotarget. 2017;8:26515-26531 pubmed publisher
  108. Ahmed S, Macara I. The Par3 polarity protein is an exocyst receptor essential for mammary cell survival. Nat Commun. 2017;8:14867 pubmed publisher
  109. He W, Wang C, Mu R, Liang P, Huang Z, Zhang J, et al. MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles. Oncogene. 2017;36:4212-4223 pubmed publisher
  110. Getahun A, Wemlinger S, Rudra P, Santiago M, van Dyk L, Cambier J. Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med. 2017;214:931-941 pubmed publisher
  111. Liu S, Gao G, Yan D, Chen X, Yao X, Guo S, et al. Effects of miR-145-5p through NRAS on the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibiting MAPK and PI3K/AKT pathways. Cancer Med. 2017;6:819-833 pubmed publisher
  112. Gupta A, Anjomani Virmouni S, Koundouros N, Dimitriadi M, Choo Wing R, Valle A, et al. PARK2 Depletion Connects Energy and Oxidative Stress to PI3K/Akt Activation via PTEN S-Nitrosylation. Mol Cell. 2017;65:999-1013.e7 pubmed publisher
  113. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed publisher
  114. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  115. Shi J, Bei Y, Kong X, Liu X, Lei Z, Xu T, et al. miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury. Theranostics. 2017;7:664-676 pubmed publisher
  116. Cen M, Hu P, Cai Z, Fang T, Zhang J, Lu M. TIEG1 deficiency confers enhanced myocardial protection in the infarcted heart by mediating the Pten/Akt signalling pathway. Int J Mol Med. 2017;39:569-578 pubmed publisher
  117. Chan L, Chen Z, Braas D, Lee J, Xiao G, Geng H, et al. Metabolic gatekeeper function of B-lymphoid transcription factors. Nature. 2017;542:479-483 pubmed publisher
  118. Zhao D, Lu X, Wang G, Lan Z, Liao W, Li J, et al. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature. 2017;542:484-488 pubmed publisher
  119. Callif B, Maunze B, Krueger N, Simpson M, Blackmore M. The application of CRISPR technology to high content screening in primary neurons. Mol Cell Neurosci. 2017;80:170-179 pubmed publisher
  120. Kang Y, Balter B, Csizmadia E, Haas B, Sharma H, Bronson R, et al. Contribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival. Nat Commun. 2017;8:14013 pubmed publisher
  121. Yue F, Bi P, Wang C, Shan T, Nie Y, Ratliff T, et al. Pten is necessary for the quiescence and maintenance of adult muscle stem cells. Nat Commun. 2017;8:14328 pubmed publisher
  122. Hichino A, Okamoto M, Taga S, Akizuki R, Endo S, Matsunaga T, et al. Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells. J Biol Chem. 2017;292:2411-2421 pubmed publisher
  123. Hill S, Nesser N, Johnson Camacho K, Jeffress M, Johnson A, Boniface C, et al. Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling. Cell Syst. 2017;4:73-83.e10 pubmed publisher
  124. Wilkerson P, Dedes K, Samartzis E, Dedes I, Lambros M, Natrajan R, et al. Preclinical evaluation of the PARP inhibitor BMN-673 for the treatment of ovarian clear cell cancer. Oncotarget. 2017;8:6057-6066 pubmed publisher
  125. Fourneaux B, Chaire V, Lucchesi C, Karanian M, Pineau R, Laroche Clary A, et al. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications. Oncotarget. 2017;8:7878-7890 pubmed publisher
  126. Mustachio L, Kawakami M, Lu Y, Rodriguez Canales J, Mino B, Behrens C, et al. The ISG15-specific protease USP18 regulates stability of PTEN. Oncotarget. 2017;8:3-14 pubmed publisher
  127. Revandkar A, Perciato M, Toso A, Alajati A, Chen J, Gerber H, et al. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nat Commun. 2016;7:13719 pubmed publisher
  128. Vidimar V, Gius D, Chakravarti D, Bulun S, Wei J, Kim J. Dysfunctional MnSOD leads to redox dysregulation and activation of prosurvival AKT signaling in uterine leiomyomas. Sci Adv. 2016;2:e1601132 pubmed
  129. Vuono E, Mukherjee A, Vierra D, Adroved M, Hodson C, Deans A, et al. The PTEN phosphatase functions cooperatively with the Fanconi anemia proteins in DNA crosslink repair. Sci Rep. 2016;6:36439 pubmed publisher
  130. Sheen M, Marotti J, Allegrezza M, Rutkowski M, Conejo Garcia J, Fiering S. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer. Oncogenesis. 2016;5:e267 pubmed publisher
  131. Cardoso R, Burns A, Moeller J, Skinner D, Padmanabhan V. Developmental Programming: Insulin Sensitizer Prevents the GnRH-Stimulated LH Hypersecretion in a Sheep Model of PCOS. Endocrinology. 2016;157:4641-4653 pubmed
  132. Hau A, Leivo M, Gilder A, Hu J, Gonias S, Hansel D. mTORC2 activation is regulated by the urokinase receptor (uPAR) in bladder cancer. Cell Signal. 2017;29:96-106 pubmed publisher
  133. Goebbels S, Wieser G, Pieper A, Spitzer S, Weege B, Yan K, et al. A neuronal PI(3,4,5)P3-dependent program of oligodendrocyte precursor recruitment and myelination. Nat Neurosci. 2017;20:10-15 pubmed publisher
  134. Visuttijai K, Pettersson J, Mehrbani Azar Y, van den Bout I, Orndal C, Marcickiewicz J, et al. Lowered Expression of Tumor Suppressor Candidate MYO1C Stimulates Cell Proliferation, Suppresses Cell Adhesion and Activates AKT. PLoS ONE. 2016;11:e0164063 pubmed publisher
  135. Song C, Liu B, Shi Y, Liu N, Yan Y, Zhang J, et al. MicroRNA-130a alleviates human coronary artery endothelial cell injury and inflammatory responses by targeting PTEN via activating PI3K/Akt/eNOS signaling pathway. Oncotarget. 2016;7:71922-71936 pubmed publisher
  136. Cizmecioglu O, Ni J, Xie S, Zhao J, Roberts T. Rac1-mediated membrane raft localization of PI3K/p110? is required for its activation by GPCRs or PTEN loss. elife. 2016;5: pubmed publisher
  137. Yuzugullu H, Von T, Thorpe L, Walker S, Roberts T, Frank D, et al. NTRK2 activation cooperates with PTEN deficiency in T-ALL through activation of both the PI3K-AKT and JAK-STAT3 pathways. Cell Discov. 2016;2:16030 pubmed publisher
  138. Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. A bead-based western for high-throughput cellular signal transduction analyses. Nat Commun. 2016;7:12852 pubmed publisher
  139. Krepler C, Xiao M, Samanta M, Vultur A, Chen H, Brafford P, et al. Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma. Oncotarget. 2016;7:71211-71222 pubmed publisher
  140. Tong L, Luo Y, Wei T, Guo L, Wang H, Zhu W, et al. KH-type splicing regulatory protein (KHSRP) contributes to tumorigenesis by promoting miR-26a maturation in small cell lung cancer. Mol Cell Biochem. 2016;422:61-74 pubmed
  141. Nip H, Dar A, Saini S, Colden M, Varahram S, Chowdhary H, et al. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer. Oncotarget. 2016;7:68371-68384 pubmed publisher
  142. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  143. Rittig N, Bach E, Thomsen H, Pedersen S, Nielsen T, Jørgensen J, et al. Regulation of Lipolysis and Adipose Tissue Signaling during Acute Endotoxin-Induced Inflammation: A Human Randomized Crossover Trial. PLoS ONE. 2016;11:e0162167 pubmed publisher
  144. Carbonneau M, M Gagné L, Lalonde M, Germain M, Motorina A, Guiot M, et al. The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. Nat Commun. 2016;7:12700 pubmed publisher
  145. Bourgonje A, Verrijp K, Schepens J, Navis A, Piepers J, Palmen C, et al. Comprehensive protein tyrosine phosphatase mRNA profiling identifies new regulators in the progression of glioma. Acta Neuropathol Commun. 2016;4:96 pubmed publisher
  146. Zhong W, Yi Q, Xu B, Li S, Wang T, Liu F, et al. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival. Nat Commun. 2016;7:12702 pubmed publisher
  147. Bi P, Yue F, Karki A, Castro B, Wirbisky S, Wang C, et al. Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice. J Exp Med. 2016;213:2019-37 pubmed publisher
  148. Georgescu M, Gagea M, Cote G. NHERF1/EBP50 Suppresses Wnt-?-Catenin Pathway-Driven Intestinal Neoplasia. Neoplasia. 2016;18:512-23 pubmed publisher
  149. Hu G, Huang K, Hu Y, Du G, Xue Z, Zhu X, et al. Single-cell RNA-seq reveals distinct injury responses in different types of DRG sensory neurons. Sci Rep. 2016;6:31851 pubmed publisher
  150. Gusscott S, Jenkins C, Lam S, Giambra V, Pollak M, Weng A. IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias. PLoS ONE. 2016;11:e0161158 pubmed publisher
  151. Chen R, Duan J, Li L, Ma Q, Sun Q, Ma J, et al. mTOR promotes pituitary tumor development through activation of PTTG1. Oncogene. 2017;36:979-988 pubmed publisher
  152. Lai M, Gonzalez Martin A, Cooper A, Oda H, Jin H, Shepherd J, et al. Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs. Nat Commun. 2016;7:12207 pubmed publisher
  153. Liu J, Wan L, Liu J, Yuan Z, Zhang J, Guo J, et al. Cdh1 inhibits WWP2-mediated ubiquitination of PTEN to suppress tumorigenesis in an APC-independent manner. Cell Discov. 2016;2:15044 pubmed publisher
  154. Hatem R, El Botty R, Chateau Joubert S, Servely J, Labiod D, de Plater L, et al. Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers. Oncotarget. 2016;7:48206-48219 pubmed publisher
  155. Takagi Y, Shimada K, Shimada S, Sakamoto A, Naoe T, Nakamura S, et al. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway. Cancer Sci. 2016;107:1270-80 pubmed publisher
  156. Kemper K, Krijgsman O, Kong X, Cornelissen Steijger P, Shahrabi A, Weeber F, et al. BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts. Cell Rep. 2016;16:263-277 pubmed publisher
  157. Oktay Y, Ülgen E, Can Ã, Akyerli C, Yüksel Å, Erdemgil Y, et al. IDH-mutant glioma specific association of rs55705857 located at 8q24.21 involves MYC deregulation. Sci Rep. 2016;6:27569 pubmed publisher
  158. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed publisher
  159. Tzani I, Ivanov I, Andreev D, Dmitriev R, Dean K, Baranov P, et al. Systematic analysis of the PTEN 5' leader identifies a major AUU initiated proteoform. Open Biol. 2016;6: pubmed publisher
  160. Hendrayani S, Al Harbi B, Al Ansari M, Silva G, Aboussekhra A. The inflammatory/cancer-related IL-6/STAT3/NF-?B positive feedback loop includes AUF1 and maintains the active state of breast myofibroblasts. Oncotarget. 2016;7:41974-41985 pubmed publisher
  161. van Ree J, Nam H, Jeganathan K, Kanakkanthara A, van Deursen J. Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes. Nat Cell Biol. 2016;18:814-21 pubmed publisher
  162. Chesnokova V, Zonis S, Zhou C, Recouvreux M, Ben Shlomo A, Araki T, et al. Growth hormone is permissive for neoplastic colon growth. Proc Natl Acad Sci U S A. 2016;113:E3250-9 pubmed publisher
  163. Garcia Carracedo D, Villaronga M, Álvarez Teijeiro S, Hermida Prado F, Santamaria I, Allonca E, et al. Impact of PI3K/AKT/mTOR pathway activation on the prognosis of patients with head and neck squamous cell carcinomas. Oncotarget. 2016;7:29780-93 pubmed publisher
  164. Yang E, Ahn S, Lee K, Mahmood U, Kim H. Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice. PLoS ONE. 2016;11:e0153298 pubmed publisher
  165. Huang G, Yang X, Chen K, Xing J, Guo L, Zhu L, et al. Porf-2 Inhibits Neural Stem Cell Proliferation Through Wnt/?-Catenin Pathway by Its GAP Domain. Front Cell Neurosci. 2016;10:85 pubmed publisher
  166. Gandin V, Masvidal L, Cargnello M, Gyenis L, McLaughlan S, Cai Y, et al. mTORC1 and CK2 coordinate ternary and eIF4F complex assembly. Nat Commun. 2016;7:11127 pubmed publisher
  167. Seneviratne U, Nott A, Bhat V, Ravindra K, Wishnok J, Tsai L, et al. S-nitrosation of proteins relevant to Alzheimer's disease during early stages of neurodegeneration. Proc Natl Acad Sci U S A. 2016;113:4152-7 pubmed publisher
  168. Missiroli S, Morganti C, Giorgi C, Pinton P. Methods to Study PTEN in Mitochondria and Endoplasmic Reticulum. Methods Mol Biol. 2016;1388:187-212 pubmed publisher
  169. Castillo Martin M, Thin T, Collazo Lorduy A, Cordon Cardo C. Immunopathologic Assessment of PTEN Expression. Methods Mol Biol. 2016;1388:23-37 pubmed publisher
  170. Domínguez Calderón A, Ávila Flores A, Ponce A, López Bayghen E, Calderón Salinas J, Luis Reyes J, et al. ZO-2 silencing induces renal hypertrophy through a cell cycle mechanism and the activation of YAP and the mTOR pathway. Mol Biol Cell. 2016;27:1581-95 pubmed publisher
  171. Lynch J, McEwen R, Crafter C, McDermott U, Garnett M, Barry S, et al. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget. 2016;7:22128-39 pubmed publisher
  172. Hayashi K, Michiue H, Yamada H, Takata K, Nakayama H, Wei F, et al. Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization. Sci Rep. 2016;6:23372 pubmed publisher
  173. Joo M, Park J, Yoo H, Lee B, Chun H, Lee S, et al. The roles of HOXB7 in promoting migration, invasion, and anti-apoptosis in gastric cancer. J Gastroenterol Hepatol. 2016;31:1717-1726 pubmed publisher
  174. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed publisher
  175. Zaldumbide L, Erramuzpe A, Guarch R, Pulido R, Cortés J, López J. Snail heterogeneity in clear cell renal cell carcinoma. BMC Cancer. 2016;16:194 pubmed publisher
  176. Dhar S, Kumar A, Zhang L, Rimando A, Lage J, Lewin J, et al. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer. Oncotarget. 2016;7:18469-84 pubmed publisher
  177. Hung M, Chen Y, Chu P, Shih C, Yu H, Tai W, et al. Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential. Oncogene. 2016;35:4891-902 pubmed publisher
  178. Gupta S, Itagaki R, Zheng X, Batkai S, Thum S, Ahmad F, et al. miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. Cardiovasc Res. 2016;110:215-26 pubmed publisher
  179. Chen N, Chyau C, Lee Y, Tseng H, Chou F. Promotion of mitotic catastrophe via activation of PTEN by paclitaxel with supplement of mulberry water extract in bladder cancer cells. Sci Rep. 2016;6:20417 pubmed publisher
  180. Egawa H, Jingushi K, Hirono T, Ueda Y, Kitae K, Nakata W, et al. The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. Sci Rep. 2016;6:20574 pubmed publisher
  181. Moudry P, Watanabe K, Wolanin K, Bartkova J, Wassing I, Watanabe S, et al. TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity. J Cell Biol. 2016;212:281-8 pubmed publisher
  182. Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam K, et al. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer. PLoS ONE. 2016;11:e0147344 pubmed publisher
  183. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  184. Siddiqui S, Akhter N, Deo S, Shukla N, Husain S. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India. Breast Cancer. 2016;23:922-931 pubmed
  185. Ho N, Morrison J, Silva A, Coomber B. The effect of 3-bromopyruvate on human colorectal cancer cells is dependent on glucose concentration but not hexokinase II expression. Biosci Rep. 2016;36:e00299 pubmed publisher
  186. Creedon H, Balderstone L, Muir M, Balla J, Gómez Cuadrado L, Tracey N, et al. Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer. Dis Model Mech. 2016;9:131-40 pubmed publisher
  187. Jin H, Gonzalez Martin A, Miletic A, Lai M, Knight S, Sabouri Ghomi M, et al. Transfection of microRNA Mimics Should Be Used with Caution. Front Genet. 2015;6:340 pubmed publisher
  188. Kang X, Song C, Du X, Zhang C, Liu Y, Liang L, et al. PTEN stabilizes TOP2A and regulates the DNA decatenation. Sci Rep. 2015;5:17873 pubmed publisher
  189. Duan S, Yuan G, Liu X, Ren R, Li J, Zhang W, et al. PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype. Nat Commun. 2015;6:10068 pubmed publisher
  190. Duchnowska R, Wysocki P, Korski K, Czartoryska Arłukowicz B, Niwińska A, Orlikowska M, et al. Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients. Oncotarget. 2016;7:550-64 pubmed publisher
  191. Messaoudi S, He Y, Gutsol A, Wight A, Hébert R, Vilmundarson R, et al. Endothelial Gata5 transcription factor regulates blood pressure. Nat Commun. 2015;6:8835 pubmed publisher
  192. Chen C, Zhu C, Huang J, Zhao X, Deng R, Zhang H, et al. SUMOylation of TARBP2 regulates miRNA/siRNA efficiency. Nat Commun. 2015;6:8899 pubmed publisher
  193. Hukelmann J, Anderson K, Sinclair L, Grzes K, Murillo A, Hawkins P, et al. The cytotoxic T cell proteome and its shaping by the kinase mTOR. Nat Immunol. 2016;17:104-12 pubmed publisher
  194. Sellerio A, Ciusani E, Ben Moshe N, Coco S, Piccinini A, Myers C, et al. Overshoot during phenotypic switching of cancer cell populations. Sci Rep. 2015;5:15464 pubmed publisher
  195. Lauková J, Kozubík A, Hofmanová J, Nekvindová J, Sova P, Moyer M, et al. Loss of PTEN Facilitates Rosiglitazone-Mediated Enhancement of Platinum(IV) Complex LA-12-Induced Apoptosis in Colon Cancer Cells. PLoS ONE. 2015;10:e0141020 pubmed publisher
  196. Zhang L, Zhang S, Yao J, Lowery F, Zhang Q, Huang W, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100-104 pubmed publisher
  197. Chen F, Rosiene J, Che A, Becker A, LoTurco J. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling. Development. 2015;142:3601-11 pubmed publisher
  198. Herranz D, Ambesi Impiombato A, Sudderth J, Sánchez Martín M, Belver L, Tosello V, et al. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015;21:1182-9 pubmed publisher
  199. Haffner M, Weier C, Xu M, Vaghasia A, Gürel B, Gümüşkaya B, et al. Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization. J Pathol. 2016;238:31-41 pubmed publisher
  200. Conde Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, et al. A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity. Nat Commun. 2015;6:8093 pubmed publisher
  201. Morley T, Xia J, Scherer P. Selective enhancement of insulin sensitivity in the mature adipocyte is sufficient for systemic metabolic improvements. Nat Commun. 2015;6:7906 pubmed publisher
  202. Lee M, Jeong M, Lee H, Han H, Ko A, Hewitt S, et al. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun. 2015;6:7769 pubmed publisher
  203. Cao X, Kaneko T, Li J, Liu A, Voss C, Li S. A phosphorylation switch controls the spatiotemporal activation of Rho GTPases in directional cell migration. Nat Commun. 2015;6:7721 pubmed publisher
  204. Lokody I, Francis J, Gardiner J, Erler J, Swain A. Pten Regulates Epithelial Cytodifferentiation during Prostate Development. PLoS ONE. 2015;10:e0129470 pubmed publisher
  205. Fedorenko I, Abel E, Koomen J, Fang B, Wood E, Chen Y, et al. Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells. Oncogene. 2016;35:1225-35 pubmed publisher
  206. Subathra M, Korrapati M, Howell L, Arthur J, Shayman J, Schnellmann R, et al. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. Am J Physiol Renal Physiol. 2015;309:F204-15 pubmed publisher
  207. Gonzalez S, Fernando R, Berthelot J, Perrin Tricaud C, Sarzi E, Chrast R, et al. In vivo time-lapse imaging of mitochondria in healthy and diseased peripheral myelin sheath. Mitochondrion. 2015;23:32-41 pubmed publisher
  208. Dorr C, Janik C, Weg M, Been R, Bader J, Kang R, et al. Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor. Mol Cancer Res. 2015;13:1238-47 pubmed publisher
  209. Demicco E, Wani K, Fox P, Bassett R, Young E, Lev D, et al. Histologic variability in solitary fibrous tumors reflects angiogenic and growth factor signaling pathway alterations. Hum Pathol. 2015;46:1015-26 pubmed publisher
  210. Heinen A, Beyer F, Tzekova N, Hartung H, Küry P. Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype. Exp Neurol. 2015;271:25-35 pubmed publisher
  211. Ruscetti M, Quach B, Dadashian E, Mulholland D, Wu H. Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis. Cancer Res. 2015;75:2749-59 pubmed publisher
  212. Liu H, Du L, Wang R, Wei C, Liu B, Zhu L, et al. High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy. Oncotarget. 2015;6:11477-91 pubmed
  213. Apostoli A, Roche J, Schneider M, SenGupta S, Di Lena M, Rubino R, et al. Opposing roles for mammary epithelial-specific PPARγ signaling and activation during breast tumour progression. Mol Cancer. 2015;14:85 pubmed publisher
  214. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed publisher
  215. Albers J, Danzer C, Rechsteiner M, Lehmann H, Brandt L, Hejhal T, et al. A versatile modular vector system for rapid combinatorial mammalian genetics. J Clin Invest. 2015;125:1603-19 pubmed publisher
  216. Li C, Cheng P, Liang M, Chen Y, Lu Q, Wang J, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015;125:1509-22 pubmed publisher
  217. Chen S, Sanjana N, Zheng K, Shalem O, Lee K, Shi X, et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell. 2015;160:1246-60 pubmed publisher
  218. Koo D, Lee H, Ahn J, Yoon D, Kim S, Gong G, et al. Tau and PTEN status as predictive markers for response to trastuzumab and paclitaxel in patients with HER2-positive breast cancer. Tumour Biol. 2015;36:5865-71 pubmed publisher
  219. Danilov C, Steward O. Conditional genetic deletion of PTEN after a spinal cord injury enhances regenerative growth of CST axons and motor function recovery in mice. Exp Neurol. 2015;266:147-60 pubmed publisher
  220. Ho J, Bassi C, Stambolic V. Characterization of nuclear PTEN and its post translational modifications. Methods. 2015;77-78:104-11 pubmed publisher
  221. Kim S, Ebbert K, Cordeiro M, Romero M, Zhu J, Serna V, et al. Cell autonomous phosphoinositide 3-kinase activation in oocytes disrupts normal ovarian function through promoting survival and overgrowth of ovarian follicles. Endocrinology. 2015;156:1464-76 pubmed publisher
  222. Blanchard Z, Paul B, Craft B, ElShamy W. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers. Breast Cancer Res. 2015;17:5 pubmed publisher
  223. Majuelos Melguizo J, Rodríguez M, López Jiménez L, Rodríguez Vargas J, Martí Martín Consuegra J, Serrano Sáenz S, et al. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma. Oncotarget. 2015;6:4790-803 pubmed
  224. Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16:178-87 pubmed publisher
  225. Mahadevan D, Theiss N, Morales C, Stejskal A, Cooke L, Zhu M, et al. Novel receptor tyrosine kinase targeted combination therapies for imatinib-resistant gastrointestinal stromal tumors (GIST). Oncotarget. 2015;6:1954-66 pubmed
  226. Grande V, Manassero G, Vercelli A. Neuroprotective and anti-inflammatory roles of the phosphatase and tensin homolog deleted on chromosome Ten (PTEN) Inhibition in a Mouse Model of Temporal Lobe Epilepsy. PLoS ONE. 2014;9:e114554 pubmed publisher
  227. Huang C, Sheng S, Li R, Sun X, Liu J, Huang G. Lactate promotes resistance to glucose starvation via upregulation of Bcl-2 mediated by mTOR activation. Oncol Rep. 2015;33:875-84 pubmed publisher
  228. Giatromanolaki A, Sivridis E, Mitrakas A, Kalamida D, Zois C, Haider S, et al. Autophagy and lysosomal related protein expression patterns in human glioblastoma. Cancer Biol Ther. 2014;15:1468-78 pubmed publisher
  229. Kong L, Wei J, Haider A, Liebelt B, Ling X, Conrad C, et al. Therapeutic targets in subependymoma. J Neuroimmunol. 2014;277:168-75 pubmed publisher
  230. Eritja N, Santacana M, Maiques O, González Tallada X, Dolcet X, Matias Guiu X. Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model. Methods. 2015;77-78:31-40 pubmed publisher
  231. Kappler C, Guest S, Irish J, Garrett Mayer E, Kratche Z, Wilson R, et al. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015;9:527-43 pubmed publisher
  232. Choi M, Nakamura T, Cho S, Han X, Holland E, Qu J, et al. Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models. J Neurosci. 2014;34:15123-31 pubmed publisher
  233. LITTLE D, Valori C, Mutsaers C, Bennett E, Wyles M, Sharrack B, et al. PTEN depletion decreases disease severity and modestly prolongs survival in a mouse model of spinal muscular atrophy. Mol Ther. 2015;23:270-7 pubmed publisher
  234. Balbas M, Burgess M, Murali R, Wongvipat J, Skaggs B, Mundel P, et al. MAGI-2 scaffold protein is critical for kidney barrier function. Proc Natl Acad Sci U S A. 2014;111:14876-81 pubmed publisher
  235. Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-187 pubmed publisher
  236. Liu Y, Wan S, Zhang P, Zhang W, Zheng J, Lin J, et al. Expression levels of autophagy related proteins and their prognostic significance in retinocytoma and retinoblastoma. Int J Ophthalmol. 2014;7:594-601 pubmed publisher
  237. Bailon E, Ugarte Berzal E, Amigo Jiménez I, Van den Steen P, Opdenakker G, Garcia Marco J, et al. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen. J Leukoc Biol. 2014;96:185-99 pubmed publisher
  238. Cha Y, Han S, Seol H, Oh D, Im S, Bang Y, et al. Immunohistochemical features associated with sensitivity to lapatinib-plus-capecitabine and resistance to trastuzumab in HER2-positive breast cancer. Anticancer Res. 2014;34:4275-80 pubmed
  239. Costales M, Lopez F, García Inclán C, Fernandez S, Marcos C, Llorente J, et al. Establishment and characterization of an orthotopic sinonasal squamous cell carcinoma mouse model. Head Neck. 2015;37:1769-75 pubmed publisher
  240. Screen M, Jonson P, Raheem O, Palmio J, Laaksonen R, Lehtimaki T, et al. Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions. Am J Pathol. 2014;184:2322-32 pubmed publisher
  241. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  242. Moriarity B, Rahrmann E, Beckmann D, Conboy C, Watson A, Carlson D, et al. Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS ONE. 2014;9:e96114 pubmed publisher
  243. Jung S, Ohk J, Jeong D, Li C, Lee S, Duan J, et al. Distinct regulatory effect of the p34SEI-1 oncoprotein on cancer metastasis in HER2/neu-positive and -negative cells. Int J Oncol. 2014;45:189-96 pubmed publisher
  244. Zhao X, Gao S, Ren H, Huang H, Ji W, Hao J. Inhibition of autophagy strengthens celastrol-induced apoptosis in human pancreatic cancer in vitro and in vivo models. Curr Mol Med. 2014;14:555-63 pubmed
  245. Melchor L, Molyneux G, Mackay A, Magnay F, Atienza M, Kendrick H, et al. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models. J Pathol. 2014;233:124-37 pubmed publisher
  246. Ma J, Liu J, Wang Z, Gu X, Fan Y, Zhang W, et al. NF-kappaB-dependent microRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1? induction. Mol Cancer. 2014;13:40 pubmed publisher
  247. Nakahata S, Ichikawa T, Maneesaay P, Saito Y, Nagai K, Tamura T, et al. Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers. Nat Commun. 2014;5:3393 pubmed publisher
  248. Miyazawa N, Yoshikawa H, Magae S, Ishikawa H, Izumikawa K, Terukina G, et al. Human cell growth regulator Ly-1 antibody reactive homologue accelerates processing of preribosomal RNA. Genes Cells. 2014;19:273-86 pubmed publisher
  249. Taguchi K, Hirano I, Itoh T, Tanaka M, Miyajima A, Suzuki A, et al. Nrf2 enhances cholangiocyte expansion in Pten-deficient livers. Mol Cell Biol. 2014;34:900-13 pubmed publisher
  250. Liu X, Chen L, Feng B, Liu G. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma. Anat Rec (Hoboken). 2014;297:215-21 pubmed publisher
  251. Morotti A, Panuzzo C, Crivellaro S, Pergolizzi B, Familiari U, Berger A, et al. BCR-ABL disrupts PTEN nuclear-cytoplasmic shuttling through phosphorylation-dependent activation of HAUSP. Leukemia. 2014;28:1326-33 pubmed publisher
  252. Haws M, JARAMILLO T, Espinosa F, Widman A, Stuber G, Sparta D, et al. PTEN knockdown alters dendritic spine/protrusion morphology, not density. J Comp Neurol. 2014;522:1171-90 pubmed publisher
  253. Wang J, Chen J, Miller D, Li W. Synergistic combination of novel tubulin inhibitor ABI-274 and vemurafenib overcome vemurafenib acquired resistance in BRAFV600E melanoma. Mol Cancer Ther. 2014;13:16-26 pubmed publisher
  254. Fernandez S, Genis L, Torres Aleman I. A phosphatase-independent gain-of-function mutation in PTEN triggers aberrant cell growth in astrocytes through an autocrine IGF-1 loop. Oncogene. 2014;33:4114-22 pubmed publisher
  255. Kucherlapati M, Esfahani S, Habibollahi P, Wang J, Still E, Bronson R, et al. Genotype directed therapy in murine mismatch repair deficient tumors. PLoS ONE. 2013;8:e68817 pubmed publisher
  256. Apostoli A, Skelhorne Gross G, Rubino R, Peterson N, Di Lena M, Schneider M, et al. Loss of PPAR? expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment. Int J Cancer. 2014;134:1055-66 pubmed publisher
  257. Carvalho K, Maia B, Omae S, Rocha A, Covizzi L, Vassallo J, et al. Best practice for PTEN gene and protein assessment in anatomic pathology. Acta Histochem. 2014;116:25-31 pubmed publisher
  258. Burkhardt L, Fuchs S, Krohn A, Masser S, Mader M, Kluth M, et al. CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res. 2013;73:2795-805 pubmed publisher
  259. Kim H, Woo H, Ryu J, Bok J, Kim J, Choi S, et al. Conditional deletion of pten leads to defects in nerve innervation and neuronal survival in inner ear development. PLoS ONE. 2013;8:e55609 pubmed publisher
  260. Ma X, Choudhury S, Hua X, Dai Z, Li Y. Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway. Carcinogenesis. 2013;34:1216-23 pubmed publisher
  261. Pérez Sieira S, Martinez G, Porteiro B, Lopez M, Vidal A, Nogueiras R, et al. Female Nur77-deficient mice show increased susceptibility to diet-induced obesity. PLoS ONE. 2013;8:e53836 pubmed publisher
  262. Lotan T, Gumuskaya B, Rahimi H, Hicks J, Iwata T, Robinson B, et al. Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2013;26:587-603 pubmed publisher
  263. Sha W, Thompson K, South J, Baron M, Leask A. Loss of PPAR? expression by fibroblasts enhances dermal wound closure. Fibrogenesis Tissue Repair. 2012;5:5 pubmed publisher
  264. Jung Y, Joo K, Seong D, Choi Y, Kong D, Kim Y, et al. Identification of prognostic biomarkers for glioblastomas using protein expression profiling. Int J Oncol. 2012;40:1122-32 pubmed publisher
  265. Lindberg K, Helguero L, Omoto Y, Gustafsson J, Haldosén L. Estrogen receptor ? represses Akt signaling in breast cancer cells via downregulation of HER2/HER3 and upregulation of PTEN: implications for tamoxifen sensitivity. Breast Cancer Res. 2011;13:R43 pubmed publisher
  266. Rodriguez O, Lai E, Vissapragada S, Cromelin C, Avetian M, Salinas P, et al. A reduction in Pten tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. Am J Pathol. 2009;174:2051-60 pubmed publisher